No definition available.
Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)
C3_MELANOMA_SKIN_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5888 |
4. Check minimum number of eventsNone |
5888 |
5. Include endpointsNone |
5888 |
6. Filter based on genotype QC (FinnGen only) |
5888 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5888 | 2814 | 3074 |
| Unadjusted period prevalence (%) | 1.17 | 0.96 | 1.36 |
| Median age at first event (years) | 62.95 | 58.90 | 66.67 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4035
- Matched controls
- 40350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
34.8
323.0
720
250
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
323.0
320
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
13.4
323.0
651
569
C61
ICD-10 Finland
Malignant neoplasm of prostate
358.0
323.0
326
10
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
1945.8
323.0
341
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
323.0
349
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
323.0
445
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
11.5
323.0
683
700
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
323.0
310
*
PJA12
NOMESCO Finland
Sentinel node biopsy
4054.0
323.0
1614
6
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
323.0
939
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
307
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
140.3
323.0
393
31
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
323.0
334
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
323.0
322
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
323.0
396
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
323.0
622
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
32.8
323.0
836
319
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
323.0
993
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
323.0
527
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
39.6
323.0
1744
760
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
323.0
356
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
323.0
633
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
323.0
863
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
18.2
323.0
965
685
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.0
323.0
989
1404
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
636
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
16.3
323.0
843
643
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
3185.6
320.8
306
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.2
319.0
1156
2873
H02AB02
ATC
dexamethasone; systemic
31.1
314.2
425
152
JN4BD
NOMESCO Finland
Extensive body CT
9.4
311.6
693
874
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
309.3
293
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
305.1
289
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
302.9
287
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
298.6
283
*
C43
ICD-10 Finland
Malignant melanoma of skin
1538.3
294.1
283
*
S77
ICPC
Malignant neoplasm of skin
291.0
268.3
271
10
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
266.6
253
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
265.5
252
*
ZZR00
NOMESCO Finland
Flap of skin
46.6
257.8
318
74
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
188.1
254.5
264
15
180
Kela drug reimbursment
Interferon alfa
+∞
251.7
239
*
S18
ICPC
Laceration/cut
3.1
247.2
2222
11433
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
204.8
242.4
250
13
L57.0
ICD-10 Finland
Actinic keratosis
5.7
240.6
769
1596
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
237.8
226
*
115
Kela drug reimbursment
Breast cancer
+∞
204.9
195
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
199.6
190
*
A04AA02
ATC
granisetron; systemic, transdermal
171.5
187.4
196
12
WF002
NOMESCO Finland
Radical radiotherapy
126.6
179.9
193
16
JN4AD
NOMESCO Finland
Body CT examination
8.1
179.4
429
585
116
Kela drug reimbursment
Prostate cancer
+∞
178.4
170
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
172.1
164
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
18.5
171.5
271
156
S82
ICPC
Naevus/mole
4.0
170.6
792
2345
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
170.0
162
*
SPAT1153
SPAT
Removal of sutures
2.7
168.7
1664
8391
ZZA00
NOMESCO Finland
Split skin graft
10.9
167.8
335
332
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
14.8
167.4
289
209
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.5
166.2
299
238
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
165.7
158
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
159.4
152
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
280.0
158.7
161
6
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
331.8
157.0
158
5
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
153.1
146
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
1505.4
147.8
143
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1480.1
145.7
141
*
D22
ICD-10 Finland
Melanocytic naevi
7.5
145.4
365
531
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
1455.0
143.6
139
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
143.6
137
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
141.4
135
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
139.3
133
*
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
+∞
139.3
133
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
139.0
1230
5672
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
135.1
129
*
L03AB05
ATC
interferon alfa-2b; parenteral
116.4
135.0
146
13
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
134.9
413
783
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
133.9
1274
6101
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1330.9
133.0
129
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
277.8
132.0
134
5
TQW99
NOMESCO Finland
Other minor procedure on skin
6.6
131.3
359
588
Z51.5
ICD-10 Finland
Palliative care
9.1
131.2
288
337
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
79.8
129.2
146
19
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
128.2
719
2432
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
1266.5
126.7
123
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
126.7
121
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
125.6
120
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
42.9
125.6
157
38
ZX090
NOMESCO Finland
Other technic of radiotherapy
419.9
123.4
123
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
17.9
119.2
190
111
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
113.0
108
*
JN4CD
NOMESCO Finland
Very extensive body CT
9.5
112.6
241
269
L01XE23
ATC
[U] dabrafenib; oral
+∞
112.0
107
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
10.3
109.0
222
226
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
1076.0
107.9
105
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
31.5
106.8
143
47
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
106.7
102
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
77.3
105.9
120
16
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
1054.9
105.8
103
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
1044.4
104.7
102
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
101.4
97
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
101.4
97
*
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
+∞
99.3
95
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
93.3
98.5
109
12
8720/3-C44.4
ICD-O-3
Malignant melanoma, NOS, of skin of scalp and neck
+∞
96.2
92
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
95.1
91
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
95.1
91
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
95.1
91
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
939.4
94.3
92
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
93.0
89
*
L82
ICD-10 Finland
Seborrhoeic keratosis
2.6
92.5
802
3532
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
92.0
859
3941
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
89.9
86
*
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
876.7
88.0
86
*
L02AE02
ATC
leuprorelin; implant, parenteral
21.6
86.1
128
61
XQ845
NOMESCO Finland
Dermatoscopy
13.9
83.9
147
109
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.2
83.7
211
305
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
83.6
1859
12367
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
83.6
80
*
HAC20
NOMESCO Finland
Total mastectomy
129.9
83.3
89
7
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
82.6
79
*
L01XE25
ATC
[U] trametinib; oral
+∞
82.6
79
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
+∞
81.5
78
*
L01AX03
ATC
temozolomide; systemic
+∞
81.5
78
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.0
81.3
120
56
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
+∞
80.5
77
*
L01BC06
ATC
capecitabine; oral
+∞
80.5
77
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
17.0
79.9
129
78
L02BG04
ATC
letrozole; oral
15.4
79.7
134
90
ZX070
NOMESCO Finland
Intensity modified radiotherapy
793.3
79.6
78
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.5
79.6
301
710
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
79.4
76
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
10.4
79.2
160
160
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
272.7
78.8
80
*
A04AA01
ATC
ondansetron; systemic, rectal
6.6
78.5
211
334
L02BA01
ATC
tamoxifen; oral
88.9
78.2
87
10
9734
FHL
Excision and local plastic or associated free skin grafting
18.5
77.9
122
68
HA1AA
NOMESCO Finland
X-ray mammography
6.1
77.1
221
381
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.4
76.6
174
214
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
163.1
76.3
80
5
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
163.1
76.3
80
5
WZC30
NOMESCO Finland
Teaching
2.9
75.6
512
1924
L03AA13
ATC
pegfilgrastim; parenteral
379.1
75.0
75
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
103.3
74.1
81
8
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
116.5
74.1
80
7
ZXC50
NOMESCO Finland
Cryotherapy
6.7
73.1
195
305
L02BB03
ATC
bicalutamide; oral
710.2
71.3
70
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
70.0
67
*
Y77
ICPC
Malignant neoplasm prostate
237.2
68.4
70
*
WX402
NOMESCO Finland
General anaesthesia
2.5
67.5
605
2667
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
122.1
67.0
72
6
JN6AD
NOMESCO Finland
CT of torso and neck
25.3
66.5
94
38
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
50.9
66.4
80
16
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.9
66.3
195
347
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
65.8
63
*
ZX080
NOMESCO Finland
Image guided radiotherapy
648.1
65.1
64
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
64.7
62
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
90.3
64.1
71
8
PJA10
NOMESCO Finland
Exploration of lymph nodes
23.2
62.9
91
40
C50.99
ICD-10 Finland
Breast, unspecified
617.1
61.9
61
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
61.6
59
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
28.8
60.2
82
29
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
209.7
60.2
62
*
XQ848
NOMESCO Finland
Dermatological photography
6.1
60.0
170
288
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.8
60.0
178
320
DAB10
NOMESCO Finland
Partial excision of auricle
596.5
59.9
59
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
596.5
59.9
59
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
59.5
57
*
C43.74
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip acral
+∞
58.5
56
*
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
17.3
58.2
93
55
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
202.8
58.2
60
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
22.5
57.6
84
38
8743/3-C44.6
ICD-O-3
Low cumulative sun damage melanoma of skin of upper limb and shoulder
+∞
57.4
55
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
11.7
56.6
107
94
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
56.4
54
*
8720/3-C44.2
ICD-O-3
Malignant melanoma, NOS, of external ear
+∞
56.4
54
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
65.9
56.4
65
10
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
72.0
56.2
64
9
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.0
55.7
77
29
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
285.2
55.3
56
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
55.3
53
*
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
+∞
55.3
53
*
C50
ICD-10 Finland
Malignant neoplasm of breast
189.1
54.1
56
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.8
53.7
158
281
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
274.5
53.3
54
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
53.2
51
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
53.2
51
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
8.5
53.2
119
143
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
39.4
52.3
66
17
L01EC02
ATC
dabrafenib; oral
+∞
52.2
50
*
L03AA02
ATC
filgrastim; parenteral
49.1
52.1
63
13
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
51.7
364
1385
ZZA50
NOMESCO Finland
Full thickness skin graft
56.2
51.6
61
11
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
60.8
51.4
60
10
R4110
NOMESCO Finland
Physiotherapy
1.8
50.6
1024
6306
WX110
NOMESCO Finland
Local anesthesy
1.7
50.3
2459
19585
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.1
50.1
292
982
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
81.2
50.0
56
7
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
49.0
47
*
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
79.7
49.0
55
7
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
49.8
49.0
59
12
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
25.0
48.9
69
28
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
91.2
48.9
54
6
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
22.5
48.8
71
32
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
483.3
48.4
48
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.9
48.0
165
351
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
48.0
46
*
C43.20
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal without histology
+∞
46.9
45
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
46.9
45
*
B01AB05
ATC
enoxaparin; parenteral
1.8
46.9
1125
7287
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
45.9
44
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
45.9
44
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
161.8
45.9
48
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
44.9
43
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
44.9
43
*
L01EE01
ATC
trametinib; oral
+∞
44.9
43
*
C43.43
ICD-10 Finland
Malignant melanoma of the scalp and neck nodular
+∞
44.9
43
*
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.9
44.8
130
228
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
442.2
44.3
44
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
44.0
3319
29184
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
15.9
43.9
72
46
17281
ICD-8 Finland
Malignant melanoma of skin, Lower limb
+∞
43.8
42
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
43.8
42
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
43.8
42
*
N02AA05
ATC
oxycodone; systemic
2.2
43.7
502
2464
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.5
43.6
134
252
S26
ICPC
Fear of cancer of skin
9.9
43.5
89
92
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.4
43.1
105
145
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
20.9
43.1
64
31
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.7
42.8
127
229
ZXA00
NOMESCO Finland
Right side
1.7
42.3
1098
7237
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
3.3
41.9
226
718
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
41.7
40
*
C43.29
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology
+∞
41.7
40
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
41.7
40
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
20.3
41.3
62
31
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
411.5
41.2
41
*
J01DB01
ATC
cefalexin; oral
1.6
40.8
3066
26507
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
40.7
39
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
40.7
39
*
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
40.7
39
*
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
40.7
39
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
11.9
40.4
75
64
A04AD12
ATC
aprepitant; systemic
401.2
40.1
40
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
401.2
40.1
40
*
A79
ICPC
Malignancy NOS
48.5
39.8
48
10
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
39.6
38
*
S29
ICPC
Skin symptom/complaint other
1.9
39.2
664
3798
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
18.4
38.8
60
33
8721/3-C44.9
ICD-O-3
Nodular melanoma of skin, NOS
+∞
38.6
37
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
38.6
37
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
24.8
38.4
54
22
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
380.7
38.1
38
*
S21
ICPC
Skin texture symptom/complaint
2.1
37.9
497
2575
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
37.5
36
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
37.5
36
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
37.5
36
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
37.5
36
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
37.3
309
1287
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
370.5
37.0
37
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
36.5
35
*
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
6.3
35.5
97
158
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
35.5
34
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
35.5
34
*
I78.1
ICD-10 Finland
Naevus, non-neoplastic
4.3
35.0
134
319
C43.41
ICD-10 Finland
Malignant melanoma of the scalp and neck originating in lentigo maligna
350.0
35.0
35
*
ZXA05
NOMESCO Finland
Left side
1.6
34.8
1003
6743
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
51.7
34.4
41
8
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
34.4
33
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
32.5
34.4
45
14
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.3
34.1
62
51
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
65.5
34.0
39
6
C43.3
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of other and unspecified parts of face
339.8
33.9
34
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
15.3
33.9
56
37
L03AB04
ATC
interferon alfa-2a; parenteral
45.9
33.7
41
9
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
33.4
32
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
33.4
32
*
17261
ICD-8 Finland
Malignant melanoma of skin, Trunk, except scrotum
+∞
33.4
32
*
9733
FHL
Excision of skin change in operating room or anesthesia
5.5
33.3
101
188
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
5.1
33.3
107
213
C44
ICD-10 Finland
Other malignant neoplasms of skin
117.6
32.7
35
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
32.3
31
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
32.3
31
*
X76
ICPC
Malignant neoplasm breast female
+∞
32.3
31
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.3
32.1
53
35
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
16.6
31.9
51
31
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
14.0
31.5
54
39
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.0
31.5
129
328
1725D
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MUU TAI TARK MÄÄR]
+∞
31.3
30
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
315.1
30.9
31
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
110.8
30.7
33
*
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
30.2
29
*
8721/3-C44.5
ICD-O-3
Nodular melanoma of skin of trunk
+∞
30.2
29
*
Z31.5
ICD-10 Finland
Genetic counselling
3.6
30.0
140
399
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
304.4
29.8
30
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
304.4
29.8
30
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
156.1
29.7
31
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
29.3
270
1187
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
29.2
28
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
66.4
28.9
33
5
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
28.1
27
*
L02BG06
ATC
exemestane; oral
+∞
28.1
27
*
L02BG03
ATC
anastrozole; oral
55.4
28.1
33
6
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
31.1
28.1
37
12
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
11.2
27.5
52
47
C43.22
ICD-10 Finland
Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type
+∞
27.1
26
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
27.1
26
*
B01AB10
ATC
tinzaparin; parenteral
2.7
27.0
189
714
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.8
27.0
92
196
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
62.4
26.9
31
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
26.9
121
335
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.3
26.7
100
235
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
140.9
26.6
28
*
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
9.4
26.6
55
59
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
19.2
26.5
40
21
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
4.1
26.3
105
262
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
26.2
540
3265
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
26.1
382
2054
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
26.1
25
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
26.1
25
*
ZZS00
NOMESCO Finland
Rotation flap
73.1
25.8
29
*
D06BB10
ATC
imiquimod; topical
2.8
25.5
173
642
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
25.2
498
2966
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
25.0
24
*
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
+∞
25.0
24
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
25.0
24
*
C43.89
ICD-10 Finland
Overall malignant melanoma of the skin other or unspecified histology
+∞
25.0
24
*
Z51.0
ICD-10 Finland
Radiotherapy session
251.6
24.7
25
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
251.6
24.7
25
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
130.7
24.6
26
*
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
3.1
24.3
138
455
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
48.6
24.3
29
6
ZX120
NOMESCO Finland
Intravenous
2.1
24.0
272
1318
17271
ICD-8 Finland
Malignant melanoma of skin, Upper limb
+∞
24.0
23
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
24.0
23
*
C43.64
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder acrally
+∞
24.0
23
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
24.0
23
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.3
24.0
74
142
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
67.8
23.8
27
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
54.3
23.0
27
5
ZX050
NOMESCO Finland
Stereotactic radiotherapy
24.8
23.0
32
13
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
22.9
22
*
QDE00
NOMESCO Finland
Excision of loose skin or fold of skin from lower limb
231.1
22.6
23
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
231.1
22.6
23
*
ZXC20
NOMESCO Finland
Use of chemical agents
4.7
22.6
77
165
ZQZ00
NOMESCO Finland
Treatment of several skin areas
17.6
22.6
35
20
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.7
22.4
153
570
WW500
NOMESCO Finland
Blood transfusion
3.5
22.2
106
309
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
22.0
277
1404
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
21.9
21
*
1725A
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MELAN EX LENTIGOMAL]
+∞
21.9
21
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
21.9
21
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
21.9
21
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
21.9
21
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
221.0
21.6
22
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.0
21.4
59
99
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
16.3
21.4
34
21
5702
FHL
Local lymph node removal (eg armpit, groin)
50.2
21.1
25
5
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
12.9
21.1
37
29
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
33.9
21.1
27
8
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
60.3
20.9
24
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
20.8
20
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
20.8
20
*
C43.80
ICD-10 Finland
Overall malignant melanoma of the skin without histology
+∞
20.8
20
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
20.8
20
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
20.8
20
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
20.8
20
*
8742/3-C44.5
ICD-O-3
Lentigo maligna melanoma of skin of trunk
+∞
20.8
20
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
20.8
20
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
3.1
20.8
114
369
WX002
NOMESCO Finland
Sedation and analgesia
1.5
20.7
701
4820
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
77.2
20.7
23
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
210.9
20.6
21
*
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
6.2
20.4
55
90
S79
ICPC
Neoplasm skin benign/unspecified
3.8
20.4
88
237
TQD05
NOMESCO Finland
Puncture of skin of lower limb
48.2
20.1
24
5
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
48.2
20.1
24
5
KCD02
NOMESCO Finland
Transurethral resection of bladder
7.2
20.0
48
67
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.5
19.9
94
273
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
19.8
1048
7918
1725B
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,SUPERFICIAL SPREAD]
+∞
19.8
19
*
1727B
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,SUPERFICIAL SPREAD]
+∞
19.8
19
*
C43.92
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type
+∞
19.8
19
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
19.8
19
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
19.8
19
*
L01EC03
ATC
encorafenib; oral
+∞
19.8
19
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
19.8
19
*
L01XE15
ATC
[U] vemurafenib; oral
+∞
19.8
19
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
73.8
19.7
22
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
73.8
19.7
22
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
105.5
19.6
21
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
200.8
19.6
20
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
17.8
19.5
30
17
L91.0
ICD-10 Finland
Hypertrophic scar
5.4
19.4
58
108
F16
ICPC
Eyelid symptom/complaint
2.3
19.3
180
799
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
46.2
19.2
23
5
ZXC96
NOMESCO Finland
Robot assisted procedure
7.0
19.1
47
68
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
12.8
18.8
33
26
L01EE03
ATC
binimetinib; oral
+∞
18.8
18
*
L02BX02
ATC
degarelix; parenteral
+∞
18.8
18
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
18.8
18
*
L02BB04
ATC
enzalutamide; oral
+∞
18.8
18
*
QBA10
NOMESCO Finland
Incision of skin of trunk
5.3
18.7
57
109
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
13.4
18.7
32
24
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
30.1
18.3
24
8
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.1
18.1
71
176
DHB00
NOMESCO Finland
Excision of lesion of external nose
9.3
18.1
37
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
18.0
399
2453
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.4
18.0
86
253
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
8.1
17.9
40
50
QB5S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in back
52.7
17.9
21
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
33.0
17.9
23
7
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
17.9
227
1153
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
10.1
17.8
35
35
XKD00
NOMESCO Finland
Uroflowmetry
1.6
17.8
555
3731
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
17.7
17
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
17.7
17
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.7
17
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
17.7
17
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
17.7
17
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
17.7
17
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.9
17.7
73
190
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
95.4
17.6
19
*
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
5.3
17.5
53
101
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
17.3
110
393
WX702
NOMESCO Finland
Supraglottic ventilation device
2.3
17.3
166
746
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
20.9
17.3
25
12
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
17.2
658
4633
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.6
17.2
79
225
A02BC02
ATC
pantoprazole; systemic
1.3
17.1
2284
19959
L03AA04
ATC
NA
31.6
17.0
22
7
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
50.2
17.0
20
*
S15
ICPC
Foreign body in skin
2.0
17.0
220
1128
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
16.8
449
2902
S08
ICPC
Skin colour change
2.2
16.8
178
837
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
63.5
16.7
19
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
63.5
16.7
19
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
16.7
16
*
1CD02
NOMESCO Finland
NA
+∞
16.7
16
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
16.7
16
*
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
+∞
16.7
16
*
C43.23
ICD-10 Finland
Malignant melanoma of the outer ear and in the outer ear canal nodular
+∞
16.7
16
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
16.7
16
*
C43.09
ICD-10 Finland
Malignant melanoma of the lip other or unspecified histology
+∞
16.7
16
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
16.7
16
*
C43.2
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of ear and external auricular canal
+∞
16.7
16
*
1725C
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,NODULARE]
+∞
16.7
16
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
16.7
16
*
8721/3-C44.7
ICD-O-3
Nodular melanoma of skin of lower limb and hip
+∞
16.7
16
*
C90.0
ICD-10 Finland
Multiple myeloma
170.6
16.5
17
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
170.6
16.5
17
*
E0000UV
ATC
NA
1.4
16.5
1275
10232
D06BX02
ATC
ingenol mebutate; topical
4.1
16.4
64
159
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
10.1
16.4
32
32
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
5.4
16.1
48
90
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
5.9
16.0
44
75
WX320
NOMESCO Finland
Spinalanesthesy
1.4
16.0
791
5867
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
8.3
15.7
34
41
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
7.3
15.7
37
51
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
15.6
15
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
15.6
15
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
15.6
15
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
15.6
15
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
15.6
15
*
C43.91
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin originating in lentigo maligna
+∞
15.6
15
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
15.6
15
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
15.6
15
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
85.4
15.6
17
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
160.5
15.5
16
*
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
3.7
15.4
66
178
R4120
NOMESCO Finland
Occupational therapy
1.9
15.4
228
1228
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
9.7
15.1
30
31
ELB50
NOMESCO Finland
Total parotidectomy
17.8
15.1
23
13
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
15.1
3204
29716
TQW20
NOMESCO Finland
Tatoe
23.4
15.1
21
9
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.7
15.0
105
400
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.0
15.0
60
153
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
14.9
98
362
WF099
NOMESCO Finland
Other radiotherapy
15.1
14.8
24
16
ZX112
NOMESCO Finland
Subcutaneous
5.6
14.8
42
75
TQW40
SPAT
NA
2.4
14.8
125
531
TQC05
NOMESCO Finland
Puncture of skin of upper limb
18.4
14.7
22
12
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.9
14.6
59
152
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
14.6
317
1934
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
14.6
14
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
14.6
14
*
L01XE41
ATC
[U] binimetinib; oral
+∞
14.6
14
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
14.6
14
*
1727D
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MUU TAI TARK MÄÄR]
+∞
14.6
14
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
14.6
14
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
14.6
14
*
8744/3-C44.9
ICD-O-3
Acral melanoma of skin, NOS
+∞
14.6
14
*
L01XE46
ATC
[U] encorafenib; oral
+∞
14.6
14
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
80.3
14.6
16
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
150.4
14.5
15
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
150.4
14.5
15
*
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
5.3
14.3
43
82
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
14.3
93
340
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.6
14.1
100
386
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
12.0
14.0
25
21
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
14.4
14.0
23
16
D18.0
ICD-10 Finland
Haemangioma, any site
2.9
14.0
83
287
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
13.9
162
795
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
12.7
13.9
24
19
R50.9
ICD-10 Finland
Fever, unspecified
1.6
13.6
393
2588
L01CA04
ATC
vinorelbine; systemic
+∞
13.5
13
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
13.5
13
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
13.5
13
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
13.5
13
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
13.5
13
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
13.5
13
*
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
+∞
13.5
13
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
13.5
13
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
13.5
13
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
6.6
13.5
34
52
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
4.3
13.5
49
115
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
140.4
13.4
14
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
13.2
176
911
A06AH03
ATC
naloxegol; oral
8.5
13.2
28
33
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.6
13.1
58
162
UKC02
NOMESCO Finland
Cystoscopy
1.5
13.1
526
3727
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.3
13.0
28
34
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
9.3
12.9
26
28
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
13.0
12.9
22
17
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.9
12.9
52
135
A98
ICPC
Health maint/preventive medicine
1.5
12.7
3609
34408
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
32.1
12.6
16
5
S04
ICPC
Lump/swelling localized
1.7
12.5
274
1675
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
12.5
12
*
C43.93
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin nodular
+∞
12.5
12
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
12.5
12
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
8721/3-C44.6
ICD-O-3
Nodular melanoma of skin of upper limb and shoulder
+∞
12.5
12
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
12.5
12
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
12.5
12
*
8743/3-C44.4
ICD-O-3
Low cumulative sun damage melanoma of skin of scalp and neck
+∞
12.5
12
*
1726B
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,SUPERFICIAL SPREAD]
+∞
12.5
12
*
C43.19
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye or other unspecified histology
+∞
12.5
12
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
12.5
12
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
12.5
12
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
L02BX03
ATC
abiraterone; oral
+∞
12.5
12
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
ZZS10
NOMESCO Finland
Transposition flap
130.3
12.4
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
12.4
315
2008
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
21.3
12.0
17
8
QCE00
NOMESCO Finland
Excision of loose skin or fold of skin from upper limb
46.8
11.9
14
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
46.8
11.9
14
*
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
10.5
11.7
22
21
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
12.5
11.6
20
16
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
4.7
11.6
38
81
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.4
11.6
54
159
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.5
11.5
29
45
-54
ICPC
Repair/fix-suture/cast/prosth device
2.4
11.5
92
382
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
7.1
11.5
27
38
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.4
11.5
54
160
XX1XN
NOMESCO Finland
Other isotope examination
+∞
11.5
11
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
11.5
11
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
11.5
11
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
11.5
11
*
1726D
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MUU TAI TARK MÄÄR]
+∞
11.5
11
*
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
+∞
11.5
11
*
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
+∞
11.5
11
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
11.5
11
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
11.5
11
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
11.5
11
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
6.7
11.4
28
42
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.4
11.4
53
156
G04BE03
ATC
sildenafil; oral
6.0
11.3
30
50
R23
ICD-10 Finland
Other skin changes
3.7
11.2
47
127
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
12.7
11.1
19
15
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.7
10.8
72
268
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
9.6
10.7
21
22
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
7.5
10.6
24
32
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
60.1
10.6
12
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
6.3
10.6
27
43
XQ902
NOMESCO Finland
Other photography
7.0
10.5
25
36
ZZR30
NOMESCO Finland
Flap of muscle
8.5
10.5
22
26
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
8.5
10.5
22
26
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
10.4
154
831
C43.21
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal originating in lentigo maligna
110.2
10.4
11
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
10.4
10
*
C43.11
ICD-10 Finland
Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna
+∞
10.4
10
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
10.4
10
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
10.4
10
*
8743/3-C44.3
ICD-O-3
Low cumulative sun damage melanoma of skin of other and unspecified parts of face
+∞
10.4
10
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
10.4
10
*
1727A
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MELAN EX LENTIGOMAL]
+∞
10.4
10
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
10.4
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
10.4
10
*
1XC18
NOMESCO Finland
NA
+∞
10.4
10
*
C43.54
ICD-10 Finland
Malignant melanoma of the torso acral
+∞
10.4
10
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
10.4
10
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
10.4
10
*
1727C
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,NODULARE]
+∞
10.4
10
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
10.4
10
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.5
10.2
35
79
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
4.9
10.2
32
66
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
10.1
709
5534
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
10.0
470
6197
D48
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other and unspecified sites
9.1
10.0
20
22
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
14.6
10.0
16
11
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
14.6
10.0
16
11
SPAT1211
SPAT
Application of soft bandage
1.6
10.0
289
1905
R23.4
ICD-10 Finland
Changes in skin texture
4.0
10.0
38
95
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
40.1
10.0
12
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
40.1
10.0
12
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
40.1
10.0
12
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.8
9.9
40
105
S97
ICPC
Chronic ulcer skin
1.7
9.9
193
1144
L02AE04
ATC
triptorelin; parenteral
26.1
9.8
13
5
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
4.5
9.7
33
74
ELB40
NOMESCO Finland
Partial parotidectomy
3.2
9.7
49
155
J01MA12
ATC
levofloxacin; systemic
1.4
9.7
549
4140
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
55.1
9.6
11
*
WF090
NOMESCO Finland
Profylactic radiotherapy
55.1
9.6
11
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
55.1
9.6
11
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
4.0
9.6
37
94
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
9.5
68
265
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
9.5
448
3268
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
10.0
9.5
18
18
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.4
9.5
76
318
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
2.0
9.5
111
550
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
100.2
9.4
10
*
D75
ICPC
Malignant neoplasm colon/rectum
30.1
9.4
12
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
9.4
9
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
9.4
9
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
9.4
9
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.4
9
*
C44.19
ICD-10 Finland
Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology
+∞
9.4
9
*
8720/3-C44.1
ICD-O-3
Malignant melanoma, NOS, of eyelid
+∞
9.4
9
*
8720/3-C44.8
ICD-O-3
Malignant melanoma, NOS, of overlapping lesion of skin
+∞
9.4
9
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
9.4
9
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
9.4
9
*
PXA20
NOMESCO Finland
Extracorporal circulation of lower extremity using heart-lung assist device
+∞
9.4
9
*
8742/3-C44.6
ICD-O-3
Lentigo maligna melanoma of skin of upper limb and shoulder
+∞
9.4
9
*
8744/3-C44.7
ICD-O-3
Acral melanoma of skin of lower limb and hip
+∞
9.4
9
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
9.4
9
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
9.4
9
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
9.4
9
*
3054
Kela drug reimbursment
NA
+∞
9.4
9
*
1523
Kela drug reimbursment
NA
+∞
9.4
9
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
9.4
9
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
9.4
9
*
C43.02
ICD-10 Finland
Malignant melanoma of lip: 'superficial spreading' type
+∞
9.4
9
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
9.4
9
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
9.4
9
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
9.4
86
384
QBA00
NOMESCO Finland
Puncture of skin of trunk
8.0
9.3
20
25
J01MA02
ATC
ciprofloxacin; systemic
1.3
9.2
1260
10738
HA1HA
NOMESCO Finland
Tomosynthesis mammography
13.7
9.2
15
11
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
9.1
156
2482
ZXB10
NOMESCO Finland
Medial
4.8
9.1
29
61
N05AX08
ATC
risperidone; systemic
0.6
9.1
102
1797
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.6
9.1
39
109
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
8.3
9.0
19
23
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
3.6
9.0
39
110
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.7
9.0
37
100
Z00.0
ICD-10 Finland
General medical examination
1.3
8.9
572
4400
HAE99
NOMESCO Finland
Other reconstruction of breast
12.5
8.8
15
12
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
12.5
8.8
15
12
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
4.8
8.8
28
59
9801
FHL
Free skin graft
6.8
8.8
21
31
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
10.7
8.8
16
15
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.8
8.7
35
93
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
50.1
8.7
10
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
4.6
8.6
28
61
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
8.6
93
449
ZZF00
NOMESCO Finland
Graft of adipose tissue
8.2
8.6
18
22
KEB00
NOMESCO Finland
Biopsy of prostate
4.2
8.5
31
75
QBE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of trunk
16.3
8.5
13
8
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
20.0
8.5
12
6
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.6
8.4
23
41
D03.8
ICD-10 Finland
Melanoma in situ of other sites
90.2
8.4
9
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
90.2
8.4
9
*
C44.79
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including hip or other unspecified histology
90.2
8.4
9
*
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3.0
8.4
46
155
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
6.7
8.3
20
30
C43.10
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye without histology
+∞
8.3
8
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
8.3
8
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
8.3
8
*
WC325
NOMESCO Finland
Demanding therapy of local tumor recidive with biomodifiers
+∞
8.3
8
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
8.3
8
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
8.3
8
*
C43.8
ICD-10 Finland
Malignant neoplasm: Overlapping malignant melanoma of skin
+∞
8.3
8
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
8.3
8
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
8.3
8
*
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
+∞
8.3
8
*
C43.81
ICD-10 Finland
Overall malignant melanoma of the skin originating in lentigo maligna
+∞
8.3
8
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
8.3
8
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
8.3
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.3
8
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.3
8
*
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
+∞
8.3
8
*
PJ003
NOMESCO Finland
Adjuvant radiotherapy of neck, clavicle and axilla
+∞
8.3
8
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
8.3
8
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
8.3
8
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.5
8.3
17
20
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.5
8.3
62
252
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
5.8
8.3
22
38
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
8.2
114
604
S59
ICPC
Skin, Other therap proced/minor surg NEC
2.9
8.2
47
161
JFF23
NOMESCO Finland
Transversostomy
6.0
8.1
21
35
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.6
8.1
35
99
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
8.1
97
489
QB3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in abdomen
17.2
8.1
12
7
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
11.7
8.1
14
12
ZZR10
NOMESCO Finland
Flap of skin and muscle
10.0
8.0
15
15
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
8.0
185
1152
QBE99
SPAT
NA
4.6
8.0
26
57
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.2
8.0
76
346
R60.0
ICD-10 Finland
Localized oedema
1.4
7.9
346
2491
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
5.4
7.8
22
41
D01AE16
ATC
amorolfine; topical
1.4
7.7
375
2750
HAB99
NOMESCO Finland
Other partial excision of mammary gland
3.8
7.7
31
83
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
45.0
7.7
9
*
XX1AD
NOMESCO Finland
Other CT-examination
45.0
7.7
9
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
45.0
7.7
9
*
TQX00
NOMESCO Finland
Needle biopsy of skin
15.0
7.7
12
8
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
3.6
7.6
32
89
-59
ICPC
Other therap proced/minor surg NEC
2.0
7.6
90
451
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
25.0
7.6
10
*
L72.1
ICD-10 Finland
Trichilemmal cyst
1.6
7.5
174
1086
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
7.5
608
7473
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
7.4
212
1394
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
80.2
7.4
8
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
80.2
7.4
8
*
OAA41
NOMESCO Finland
Health check based on individual needs
80.2
7.4
8
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.6
7.4
52
205
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
+∞
7.3
7
*
1XC17
NOMESCO Finland
NA
+∞
7.3
7
*
4CJ01
NOMESCO Finland
NA
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
7.3
7
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
7.3
7
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
+∞
7.3
7
*
QA3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in ear
+∞
7.3
7
*
PJ5SN
NOMESCO Finland
Sentinell SPECT with low dose CT
+∞
7.3
7
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
+∞
7.3
7
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
8721/3-C44.3
ICD-O-3
Nodular melanoma of skin of other and unspecified parts of face
+∞
7.3
7
*
C18
ICD-10 Finland
Malignant neoplasm of colon
+∞
7.3
7
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
7.3
7
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
7.3
7
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
+∞
7.3
7
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
7.3
7
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
7.3
7
*
1726A
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MELAN EX LENTIGOMAL]
+∞
7.3
7
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
7.3
7
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
7.3
7
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
7.3
7
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
7.3
7
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
7.3
7
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
7.3
7
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
7.3
7
*
G04BE09
ATC
vardenafil; oral
+∞
7.3
7
*
L04AX04
ATC
lenalidomide; oral
+∞
7.3
7
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
7.3
7
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
7.3
7
*
D23
ICD-10 Finland
Other benign neoplasms of skin
2.4
7.3
58
244
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.5
7.3
253
1739
JG1BG
NOMESCO Finland
MRI of rectum
15.7
7.2
11
7
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
15.7
7.2
11
7
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.2
7.2
35
110
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
7.3
7.2
16
22
M05BX04
ATC
denosumab; parenteral
1.8
7.2
110
610
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.0
7.1
89
456
HA1SA
NOMESCO Finland
Expansion mammography
30.0
7.1
9
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.4
7.1
24
55
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
2.4
7.1
54
223
KAC10
NOMESCO Finland
Total nephrectomy with capsule
12.0
7.1
12
10
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.0
1355
11897
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
7.0
42
151
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
2.7
6.9
45
169
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.0
6.9
85
432
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
6.9
571
7002
WVA20
NOMESCO Finland
Medicine administration
2.3
6.8
61
273
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
6.8
176
1130
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
6.8
252
1759
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
9.3
6.8
13
14
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
6.8
102
560
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
6.1
6.8
17
28
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
40.1
6.8
8
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
40.1
6.8
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
40.1
6.8
8
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
40.1
6.8
8
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
40.1
6.8
8
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
3.2
6.7
32
99
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
16.7
6.7
10
6
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.5
6.7
52
1017
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.4
6.7
51
211
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
22.5
6.7
9
*
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
6.4
6.6
16
25
KC1GB
NOMESCO Finland
Cystography with X-ray
7.8
6.6
14
18
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
6.6
217
1479
PJW99
NOMESCO Finland
Other operation on lymphatic system
69.9
6.4
7
*
329
Kela drug reimbursment
Lenalidomide
69.9
6.4
7
*
153
Kela drug reimbursment
Lenalidomid
69.9
6.4
7
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
69.9
6.4
7
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.0
6.4
77
390
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
3.5
6.4
27
77
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.4
524
4172
B01AB04
ATC
dalteparin; parenteral
1.7
6.3
134
818
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
6.5
6.3
15
23
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
9.2
6.3
12
13
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
6.3
267
1915
JG1CG
NOMESCO Finland
Extensive MRI of rectum
18.0
6.3
9
5
7323
FHL
Electrosection of TU bladder wall change
18.0
6.3
9
5
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.2
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.2
6
*
8721/3-C44.4
ICD-O-3
Nodular melanoma of skin of scalp and neck
+∞
6.2
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.2
6
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
6.2
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.2
6
*
8743/3-C44.2
ICD-O-3
Low cumulative sun damage melanoma of external ear
+∞
6.2
6
*
17241
ICD-8 Finland
Malignant melanoma of skin, Scalp and neck
+∞
6.2
6
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.2
6
*
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
6.2
6
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
6.2
6
*
1726C
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,NODULARE]
+∞
6.2
6
*
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
6.2
6
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
6.2
6
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
6.2
6
*
L03AB01
ATC
interferon alfa natural; parenteral
+∞
6.2
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.2
6
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
6.2
6
*
C43.94
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin acrally
+∞
6.2
6
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
6.2
6
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
6.2
6
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
6.2
6
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.2
6
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
6.2
6
*
C43.83
ICD-10 Finland
Overall malignant melanoma of the skin nodular
+∞
6.2
6
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
6.2
6
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
6.2
6
*
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
6.2
6
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
6.2
6
*
189
Kela drug reimbursment
Imatinib
+∞
6.2
6
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
6.2
6
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
6.2
6
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
6.2
6
*
C43.1
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of eyelid, including canthus
+∞
6.2
6
*
R03BB04
ATC
tiotropium bromide; inhalant
0.7
6.2
171
2468
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.2
213
1463
D03.30
ICD-10 Finland
Melanoma in situ on the lip
26.7
6.2
8
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.5
6.2
50
967
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
6.2
776
6506
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
4.1
6.2
22
54
F03
ICD-10 Finland
Unspecified dementia
0.5
6.2
51
974
H02AB09
ATC
hydrocortisone; systemic
2.1
6.1
64
308
B07.9
ICD-10 Finland
Verruca simplex
1.9
6.1
85
457
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
12.5
6.1
10
8
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
12.5
6.1
10
8
SPAT1058
SPAT
PEF monitoring instruction
0.6
6.0
125
1904
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1536
4625
4.14
307.65
7.9
2.7
u/l
241.5
239.8
0.10
1492
4265
(3002256) Pathology report gross observation
2115
3642
8.50
307.65
1.8
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4149
14899
7.04
307.65
3.8
1.7
—
—
—
0
0
(4035726)
1552
1357
15.17
307.65
1.5
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
189
94
20.74
248.70
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
298
396
7.87
211.88
1.8
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
674
1937
3.80
201.04
1.3
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3283
22403
2.05
153.68
9.1
3.8
umol/l
11.6
12.0
1.01
3155
20910
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
706
2503
3.07
149.00
3.6
1.4
ug/l
12.8
8.6
0.27
547
1865
(3044640) Blood type and Crossmatch panel - Blood
2183
13115
2.06
142.47
2.5
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2947
19841
1.97
137.65
4.0
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3444
24627
1.96
132.81
11.7
6.3
e9/l
4.1
4.3
6.74
3022
21087
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
286
604
4.93
126.77
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
846
3723
2.49
115.93
6.8
1.8
nmol/l
374.5
366.2
0.63
810
3355
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4373
35169
1.95
104.64
10.6
5.4
u/l
79.8
76.1
4.93
4141
32487
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1673
10015
1.94
103.49
2.4
2.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
305
802
3.96
101.79
1.4
1.3
u/l
14.4
10.0
4.84
252
634
(3033658) Prothrombin time (PT) actual/Normal
1761
10788
1.90
101.15
4.1
3.5
%
88.1
86.6
1.57
1735
10491
(3015377) Calcium [Moles/volume] in Serum or Plasma
2197
14643
1.80
94.82
5.5
2.1
mmol/l
2.4
2.4
2.23
1934
12168
(40768793) Breast Pathology biopsy report
154
261
6.03
86.80
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2198
15012
1.74
84.69
7.1
5.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
55
20
27.75
81.12
1.1
1.0
ug/l
1.7
1.3
—
23
9
(40758558) Short blood count panel - Blood
1638
10393
1.80
80.69
9.2
4.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2971
22468
1.65
74.98
7.0
5.4
e9/l
0.0
0.0
0.55
2528
19217
(3001604) Monocytes [#/volume] in Blood
2949
22319
1.64
73.71
7.1
5.4
e9/l
0.6
0.6
3.51
2513
19070
(3024561) Albumin [Mass/volume] in Serum or Plasma
2633
19413
1.64
72.69
6.0
3.8
g/l
35.3
35.5
1.32
2474
17710
(40768800) Prostate Pathology biopsy report
165
351
4.81
72.33
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3036
23232
1.63
71.90
7.2
5.5
e9/l
0.2
0.2
2.70
2624
20168
(3019198) Lymphocytes [#/volume] in Blood
3003
22929
1.63
71.66
7.1
5.4
e9/l
2.0
1.8
1.35
2605
19956
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
60
37
16.37
71.04
6.5
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2699
20107
1.63
70.87
7.3
5.6
%
0.7
0.7
1.19
2512
18471
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2799
21066
1.63
70.31
6.4
5.3
mmol/l
1.2
1.2
1.05
2553
18614
(3019069) Monocytes/100 leukocytes in Blood
2768
20839
1.62
68.97
7.5
5.9
%
8.7
8.7
0.24
2591
19208
(3006504) Eosinophils/100 leukocytes in Blood
2750
20711
1.62
68.12
7.3
5.6
%
2.9
3.0
0.29
2560
19002
(3002030) Lymphocytes/100 leukocytes in Blood
2810
21303
1.61
67.51
7.4
5.7
%
27.1
27.2
0.16
2616
19517
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3017
23379
1.60
65.27
6.9
5.7
mmol/l
1.2
1.2
1.82
2532
19588
(3018010) Neutrophils/100 leukocytes in Blood
2762
21095
1.58
62.57
7.1
5.6
%
57.7
57.9
0.26
2578
19440
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1315
8352
1.74
61.97
4.7
2.2
mmol/l
2.5
2.4
3.00
1170
7132
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1112
6756
1.80
61.00
3.5
2.5
mmol/l
0.8
0.8
0.14
1032
6180
(3018418) pH of Serum or Plasma
1914
13513
1.62
59.70
4.9
3.3
ph
7.4
7.4
0.07
364
2350
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
263
889
3.05
59.11
3.1
1.9
u/ml
1601.9
97.9
0.83
232
708
(3013826) Glucose [Moles/volume] in Serum or Plasma
3422
27850
1.55
55.69
5.6
4.4
mmol/l
6.7
6.8
2.73
3271
25958
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4921
43761
1.76
54.51
18.3
12.4
ml/min/173m2
76.3
76.5
0.30
4284
35399
(3021589) Normoblasts [#/volume] in Blood
2560
19837
1.51
50.40
11.4
8.7
e9/l
0.0
0.0
0.15
2089
16196
(3023368) Bacteria identified in Blood by Culture
1715
12582
1.51
41.81
4.3
3.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5297
48922
1.82
41.42
21.1
16.4
mmol/l
139.7
139.8
0.66
5196
47586
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
52
60
8.73
41.35
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2480
19611
1.46
41.32
10.1
10.6
inr
1.3
1.3
0.81
675
5421
(3023103) Potassium [Moles/volume] in Serum or Plasma
5306
49054
1.83
41.01
21.3
16.5
mmol/l
4.0
4.0
6.16
5196
47629
(3003694) ABO and Rh group [Type] in Blood
1524
10968
1.53
40.43
1.4
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
78
146
5.40
39.65
5.5
1.1
u/ml
117.0
132.5
0.07
28
40
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5069
46383
1.67
39.20
18.2
13.5
mg/l
25.4
24.0
2.08
4206
36441
(3042936) Bacteria identified in Isolate by Culture
966
6312
1.63
38.77
2.0
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1661
12302
1.49
37.91
3.6
2.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
279
1217
2.36
37.72
1.3
1.3
iu/l
27.6
32.0
1.37
228
1052
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
133
393
3.44
37.33
1.6
1.3
u/l
32.9
31.7
0.13
125
287
(3007853) Bacteria identified in Skin by Aerobe culture
836
5343
1.66
36.44
1.9
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1709
12810
1.47
36.43
3.7
3.0
e6/l
0.4
0.5
0.66
1300
9548
(3021387) Prolactin [Units/volume] in Serum or Plasma
232
948
2.51
36.21
1.8
1.7
mu/l
292.6
298.2
0.11
218
856
(3018095) Leukocytes [#/volume] in Urine
2084
16251
1.44
35.91
4.1
3.5
e6/l
92.0
111.1
0.51
1513
11422
(3031040) Bacteria [#/volume] in Urine by Automated count
3574
30668
1.42
35.74
4.5
4.4
e6/l
715.9
1971.0
1.41
50
466
(3002582) Erythrocytes [#/volume] in Urine
1822
13904
1.45
35.08
3.7
3.1
e6/l
114.1
103.3
0.08
1412
10555
(3017446) Testosterone [Moles/volume] in Serum or Plasma
491
2736
1.87
34.50
2.0
2.2
nmol/l
11.5
14.4
10.38
432
2368
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
632
3833
1.73
33.35
3.0
2.2
u/l
34.5
50.1
0.65
559
3235
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
235
1009
2.38
32.93
1.5
1.8
iu/l
3.7
4.6
0.43
55
334
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1880
14613
1.42
32.06
4.8
2.3
u/l
58.0
59.4
0.68
1732
13377
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5307
49621
1.70
32.03
13.9
9.3
u/l
25.4
25.5
0.06
5144
47438
(40761511) CBC panel - Blood by Automated count
5177
48143
1.62
31.39
16.3
13.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
23
11
20.99
30.29
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
43
58
7.46
30.09
11.4
1.5
u/l
63.5
44.1
0.46
15
19
(3007461) Platelets [#/volume] in Blood
5444
51434
1.78
29.37
27.3
19.9
e9/l
244.9
244.7
0.08
5336
49837
(3024731) MCV [Entitic volume]
5444
51452
1.77
29.09
27.2
19.8
fl
91.2
91.4
2.37
5380
50504
(3026361) Erythrocytes [#/volume] in Blood
5444
51457
1.77
29.01
27.3
19.9
e12/l
4.5
4.5
3.25
5329
49667
(3000963) Hemoglobin [Mass/volume] in Blood
5444
51465
1.77
28.88
27.4
20.0
g/l
134.3
135.9
12.71
5385
50528
(3035941) MCH [Entitic mass]
5442
51453
1.76
28.69
27.1
19.8
pg
30.3
30.4
4.78
5378
50506
(3010813) Leukocytes [#/volume] in Blood
5442
51468
1.76
28.46
27.3
19.9
e9/l
6.8
6.8
0.66
5321
49674
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
552
3401
1.69
27.27
2.0
2.0
g/l
0.2
0.2
2.89
518
3090
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1015
7216
1.49
27.06
3.3
2.7
e6/l
1.8
2.5
2.34
557
3922
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
669
4352
1.61
26.64
1.6
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
270
1347
2.05
26.14
2.2
1.5
u/ml
37.6
25.5
0.61
261
1278
(3021879) Hepatitis B virus core Ab [Presence] in Serum
402
2295
1.81
25.97
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
586
3723
1.64
25.66
1.6
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4163
37530
1.37
25.64
22.4
16.1
%
13.8
13.7
4.29
4108
36583
(3014576) Chloride [Moles/volume] in Serum or Plasma
839
5794
1.52
25.60
7.3
6.4
mmol/l
104.3
104.3
0.08
828
5648
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
699
4679
1.56
24.52
2.8
2.2
umol/l
9.4
8.0
0.85
618
4024
(3003458) Phosphate [Moles/volume] in Serum or Plasma
837
5847
1.50
24.07
6.6
5.5
mmol/l
1.0
1.0
0.23
786
5352
(3044889) 12 lead EKG panel
3771
33618
1.34
24.06
4.5
4.0
—
—
—
0
0
(3026782) Osmolality of Urine
1189
8910
1.42
23.65
3.1
2.7
mosm/kgh2o
549.9
550.3
0.02
1019
7426
(3000850) Epithelial cells [#/volume] in Urine
1277
9712
1.40
23.28
2.9
2.5
e6/l
4.5
4.8
0.35
1120
8372
(3014111) Lactate [Moles/volume] in Serum or Plasma
613
4048
1.57
22.75
6.0
6.5
mmol/l
1.4
1.4
0.20
587
3893
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
693
4726
1.53
22.23
3.7
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3951
35635
1.33
22.22
4.9
3.9
pmol/l
15.0
14.9
1.56
3580
32049
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1067
7928
1.42
22.09
3.2
2.6
e6/l
1.8
1.2
0.62
607
4599
(3037467) Urinalysis macro (dipstick) panel - Urine
3620
32337
1.31
21.29
4.4
4.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1275
9837
1.38
21.03
4.9
4.0
ng/l
161.5
518.3
8.00
1057
8079
(3049717) Cytology report of Urine Cyto stain
290
1598
1.86
21.00
2.7
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
568
3757
1.57
20.86
8.0
7.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1732
14024
1.33
20.80
3.8
2.6
u/l
31.5
34.2
1.15
1631
13184
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
145
627
2.35
20.10
4.7
5.4
iu/ml
378.1
723.8
0.49
24
88
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
33
52
6.38
20.07
1.3
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
610
4151
1.52
19.66
7.2
7.0
mmol/l
10.5
11.0
1.01
586
3915
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
380
2336
1.67
18.81
7.8
9.0
mmol/l
24.4
24.4
0.05
359
2129
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
74
235
3.18
18.68
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4647
43305
1.35
18.47
5.9
4.7
mu/l
2.0
2.1
1.22
4229
39223
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
394
2460
1.64
18.36
4.0
3.0
pmol/l
4.4
4.4
0.73
366
2132
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
114
469
2.46
17.69
2.7
2.5
u/ml
671.4
509.4
—
5
29
(3009542) Hematocrit [Volume Fraction] of Blood
4422
41024
1.31
17.35
19.8
14.9
%
39.7
39.5
0.79
3056
27161
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
63
191
3.32
17.17
2.5
1.9
e6/l
497.8
712.3
1.32
17
83
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
437
2859
1.57
16.77
1.6
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
66
212
3.14
16.39
1.7
2.1
%
36.2
44.5
—
6
28
(3004809) Band form neutrophils/100 leukocytes in Blood
125
561
2.25
15.97
3.6
2.8
%
1.1
1.3
0.31
95
418
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1000
7748
1.35
15.50
1.8
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1864
15727
1.27
15.34
3.0
3.1
ng/l
1547.1
1540.1
0.02
1621
13536
(40768441) Liver Pathology biopsy report
58
181
3.23
15.13
1.1
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
294
1790
1.68
15.11
2.5
2.3
ug/l
299.4
661.2
1.97
281
1689
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
396
2603
1.56
14.87
1.3
1.2
iu/ml
124.1
134.1
0.17
103
994
(40760892) CBC W Ordered Manual Differential panel - Blood
1170
9361
1.31
14.41
5.0
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
89
361
2.49
14.32
1.9
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
118
543
2.20
14.23
3.5
1.9
u/ml
113.0
531.8
0.78
109
495
(46235355) HIV 1 and 2 tests - Meaningful Use set
694
5148
1.39
14.03
1.7
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
151
768
1.99
14.00
3.8
3.6
%
57.3
58.6
0.58
151
768
(3018677) aPTT in Platelet poor plasma by Coagulation assay
937
7324
1.33
13.53
2.0
1.9
s
30.3
30.0
0.87
902
7086
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1299
10637
1.28
13.27
3.5
2.8
ug/l
0.8
0.7
0.99
973
7401
(3045142) Bone marrow Pathology biopsy report
82
334
2.48
13.11
1.3
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3798
35099
1.23
12.53
4.1
4.2
mm/h
12.6
12.4
0.34
3484
32248
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
246
1506
1.66
12.43
2.3
3.0
u/ml
0.4
0.3
0.64
142
869
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4880
46452
1.30
12.15
5.3
4.9
mmol/l
6.0
6.0
3.37
4404
42039
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
81
343
2.38
11.94
1.9
1.8
u/ml
108.6
465.1
0.43
81
330
(3022145) Colonoscopy Study observation
627
4708
1.37
11.70
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
28
63
4.46
11.64
1.1
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2191
19258
1.22
11.55
2.2
2.2
nmol/l
79.5
78.7
0.60
1928
16897
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1840
15900
1.23
11.44
2.4
2.2
u/l
178.5
235.4
2.68
1747
14829
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
121
613
1.99
11.42
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
64
252
2.56
11.04
1.6
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
106
520
2.06
10.95
1.7
1.5
g/l
31.3
28.8
1.38
93
454
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
183
1072
1.73
10.93
2.1
2.2
g/l
3.6
3.6
0.12
177
1007
(3052851) Hemolysis interference index of Serum or Plasma
218
1343
1.65
10.79
3.5
3.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
87
398
2.20
10.75
4.3
3.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
90
418
2.17
10.72
1.6
1.5
e6/l
75143.0
63592.3
0.15
49
247
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
811
6409
1.31
10.66
2.9
2.7
%
22.6
22.5
0.07
709
5351
(3000494) Fungus identified in Specimen by Culture
684
5281
1.33
10.61
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
97
466
2.10
10.60
1.6
1.5
e6/l
1636.5
2855.3
1.01
68
344
(3013512) EKG study
1694
14612
1.22
10.53
4.5
4.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
44
146
3.03
10.47
2.9
2.2
%
32.7
43.8
—
6
57
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
177
1043
1.72
10.37
2.3
2.2
%
196.9
190.4
0.39
169
991
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
188
1129
1.69
10.28
1.9
1.9
%
93.7
90.6
0.93
177
1057
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
206
1268
1.65
10.25
1.6
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
693
5393
1.32
10.16
6.2
6.9
mmol/l
0.8
1.3
2.20
557
4139
(3027801) Oxygen [Partial pressure] in Arterial blood
696
5428
1.32
10.04
6.2
6.9
kpa
12.9
11.6
7.34
666
5149
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
696
5431
1.32
10.00
6.2
6.9
kpa
5.0
5.1
0.21
667
5167
(3012441) Differential panel - Pleural fluid
84
391
2.16
9.98
1.7
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
858
6889
1.29
9.96
2.7
2.6
g/l
2.3
2.3
1.46
798
6314
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
124
671
1.87
9.69
1.5
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
36
5.29
9.62
1.0
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
61
252
2.44
9.57
1.2
1.3
u/l
9.6
11.9
1.05
55
224
(3017181) Myelocytes/100 leukocytes in Blood
483
3594
1.37
9.51
4.3
3.7
%
1.0
0.7
1.28
150
779
(3036489) Thrombin time
232
1500
1.57
9.45
1.8
1.8
s
21.2
21.2
0.03
211
1313
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
320
2219
1.47
9.37
5.0
4.1
mmol/l
24.1
24.2
0.19
294
1962
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2134
18979
1.20
9.37
5.8
4.0
ug/l
3.5
2.4
1.43
1899
16989
(3017354) Segmented neutrophils/100 leukocytes in Blood
79
369
2.16
9.33
3.4
2.6
%
56.1
59.1
0.41
48
236
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
146
842
1.75
9.27
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1512
13033
1.22
9.24
3.0
2.5
umol/l
5088.0
5827.3
0.26
1310
11083
(3027945) Reticulocytes/100 erythrocytes in Blood
695
5490
1.30
9.11
2.6
2.1
%
1.8
1.7
1.07
620
4757
(3010370) Gastrin [Moles/volume] in Serum or Plasma
19
39
4.88
8.82
3.4
1.4
pmol/l
72.0
28.5
0.58
19
29
(40758292) HTLV I+II Ab panel - Serum
16
28
5.73
8.79
1.2
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
570
4402
1.33
8.79
7.0
7.7
g/l
120.3
122.6
2.02
552
4229
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
682
5406
1.30
8.70
1.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
683
5425
1.29
8.57
1.7
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1621
14155
1.20
8.53
3.0
3.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
459
3458
1.36
8.37
4.4
3.8
%
0.1
0.1
0.54
141
726
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
0
+∞
8.33
1.1
0.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
116
648
1.81
8.25
1.7
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
491
3745
1.34
8.25
4.9
3.0
mmol/l
1.2
1.2
0.28
435
3155
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
108
597
1.82
7.97
1.5
1.4
u/ml
120.1
126.1
0.18
18
111
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
199
1295
1.56
7.94
1.2
1.2
—
—
—
0
0
(4281824)
55
237
2.33
7.93
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
437
3297
1.35
7.90
4.0
3.6
%
0.5
0.5
0.02
111
585
(3020630) Protein [Mass/volume] in Serum or Plasma
513
3965
1.32
7.87
2.8
1.6
g/l
65.9
66.7
1.62
459
3513
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2175
19590
1.17
7.84
4.2
3.9
ng/l
44.8
85.7
1.51
1639
14127
(3042111) Morphology [Interpretation] in Bone marrow Narrative
109
608
1.81
7.82
1.4
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
527
4094
1.32
7.80
2.8
2.2
e9/l
69.9
68.5
0.39
373
3118
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
421
3165
1.36
7.79
1.5
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
874
7237
1.24
7.72
27.7
28.9
inr
1.3
1.5
1.12
96
966
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
315
2262
1.41
7.69
1.7
1.6
g/l
1.5
1.5
0.76
275
1926
(3014765) Yersinia sp identified in Stool by Organism specific culture
199
1306
1.54
7.66
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
277
1948
1.44
7.59
2.1
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
199
1314
1.53
7.46
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
900
7506
1.23
7.43
2.7
2.6
umol/l
12.6
12.9
0.50
838
6874
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
33
4.86
7.40
1.3
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
612
4887
1.28
7.35
6.6
7.2
%
96.2
95.1
6.22
591
4689
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1723
15291
1.18
7.32
4.8
3.9
%
22.2
24.2
7.16
940
7585
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
60
278
2.17
7.32
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
256
1798
1.44
7.09
1.8
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
84
446
1.90
7.08
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
154
973
1.60
7.02
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
61
291
2.11
6.93
2.3
2.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
13
24
5.43
6.76
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2713
25076
1.15
6.57
2.5
2.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
41
4.16
6.54
1.2
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
41
4.16
6.54
1.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
41
4.16
6.54
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
467
3663
1.30
6.45
4.6
4.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
25
80
3.13
6.42
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
424
3286
1.31
6.40
4.3
3.9
%
0.1
0.3
0.50
117
633
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
57
274
2.09
6.38
1.4
1.4
u/l
12.9
13.2
0.10
52
264
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
67
342
1.97
6.37
1.4
1.3
u/l
422.6
309.7
0.78
67
324
(3045788) Cell count panel - Pleural fluid
70
364
1.93
6.32
1.7
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
468
3683
1.29
6.31
4.2
3.8
ng/l
104.4
95.8
0.83
404
3093
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
61
3.45
6.27
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
593
4810
1.26
6.26
4.5
3.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1155
10031
1.19
6.19
1.6
1.7
mg/l
1.5
1.2
0.87
901
7691
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
193
1320
1.48
6.18
2.2
1.5
g/l
0.0
0.0
0.00
170
1207
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
216
1511
1.45
6.16
2.3
3.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
196
1346
1.47
6.15
2.1
1.5
g/l
0.0
0.0
0.50
170
1213
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2080
18957
1.15
5.96
3.0
2.9
ug/l
147.1
129.7
1.66
1897
17334
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3082
28854
1.14
5.96
3.1
3.0
u/l
51.2
47.7
1.09
2841
26396
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
141
910
1.56
5.94
1.7
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
41
179
2.30
5.83
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
46
211
2.19
5.83
5.0
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
360
2769
1.32
5.76
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
74
406
1.83
5.71
1.8
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
106
647
1.65
5.63
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
226
1622
1.41
5.63
2.3
1.5
g/l
1.1
0.5
1.27
185
1375
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
205
1447
1.43
5.60
2.1
1.5
g/l
0.0
0.0
1.09
179
1311
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
26
93
2.80
5.55
1.1
1.3
ug/l
17.5
89.0
0.84
11
37
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
143
941
1.53
5.55
1.6
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
45
209
2.16
5.55
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
190
1326
1.45
5.53
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2320
21386
1.14
5.51
2.1
2.1
pmol/l
94.2
94.4
0.07
1211
11063
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
108
667
1.63
5.49
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
378
2953
1.30
5.42
2.8
2.3
g/l
10.1
10.8
1.90
344
2688
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
77
437
1.77
5.35
1.2
1.2
u/l
50.1
57.2
0.51
48
273
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
313
2387
1.33
5.34
8.6
9.7
—
—
—
0
0
(3036603) Volume of Urine
55
281
1.97
5.29
1.6
1.4
ml
1828.5
1917.4
—
8
67
(3051611) Lipemic interference index of Serum or Plasma
77
439
1.76
5.27
4.2
3.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
248
1832
1.37
5.23
2.3
1.5
g/l
3.1
3.0
0.04
183
1407
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
132
2.43
5.19
4.0
2.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
97
592
1.65
5.19
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4931
47903
1.18
5.15
5.3
5.3
mmol/l
2.7
2.7
0.03
4451
43933
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
212
1535
1.40
5.06
2.1
1.4
g/l
38.1
37.6
0.70
176
1287
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1373
12270
1.16
5.03
2.2
2.3
mg/l
3.0
2.9
0.40
1176
10395
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4789
46437
1.17
5.01
4.7
4.7
mmol/l
1.5
1.4
0.08
4325
42493
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
33
141
2.35
4.98
2.6
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4619
44675
1.16
4.96
6.3
6.4
mmol/mol
40.1
40.6
2.87
4195
41081
(3037756) Immunofixation for Serum or Plasma
139
934
1.50
4.94
1.5
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
49
247
1.99
4.92
2.7
2.1
e9/l
1.1
1.0
0.28
31
144
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
30
124
2.43
4.87
2.8
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
39
181
2.16
4.86
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
39
181
2.16
4.86
1.3
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
259
1951
1.34
4.84
2.3
1.4
g/l
3.5
3.9
4.46
183
1377
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
259
1953
1.34
4.81
2.3
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
39
182
2.15
4.80
1.8
2.0
%
17.8
16.2
0.20
15
84
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30
125
2.41
4.79
2.8
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30
125
2.41
4.79
2.8
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
259
1955
1.34
4.78
2.3
1.4
g/l
7.2
7.5
1.88
186
1431
(3023410) Appearance of Cerebral spinal fluid
69
393
1.76
4.78
1.2
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
243
1819
1.35
4.74
2.3
1.5
g/l
9.6
10.4
1.74
193
1509
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4637
44903
1.15
4.73
4.2
4.2
mmol/l
1.3
1.3
0.06
4144
40737
(1616796) Gas panel - Central venous blood
147
1009
1.47
4.72
3.3
3.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4818
46798
1.16
4.67
4.7
4.7
mmol/l
4.6
4.6
0.11
4381
43109
(3048929) Epstein Barr virus Ab [Presence] in Serum
133
898
1.49
4.64
1.2
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
35
159
2.21
4.61
2.6
2.2
e9/l
0.2
0.1
0.34
35
152
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
96
604
1.60
4.60
1.3
1.2
u/ml
243.4
280.2
0.79
61
383
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
152
1057
1.45
4.57
3.8
2.6
mg/l
1.7
1.7
0.04
142
936
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
65
370
1.77
4.53
1.9
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
39
187
2.09
4.50
1.9
2.0
%
67.0
72.1
0.88
39
176
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
640
5431
1.20
4.40
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
462
3797
1.24
4.38
3.5
2.4
ml/min/173m2
59.4
63.3
1.33
194
1467
(21494814) CD8 cells/100 lymphocytes in Specimen
24
94
2.56
4.37
1.4
2.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
58
327
1.78
4.20
1.4
1.3
nmol/l
0.2
0.3
0.31
44
264
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
11
27
4.08
4.16
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
241
1844
1.32
4.10
1.8
1.8
ug/l
1.8
1.7
0.07
205
1587
(3021960) Folate [Moles/volume] in Serum or Plasma
1337
12080
1.14
4.09
1.6
1.5
nmol/l
20.2
20.3
0.06
1131
10209
(3016228) CD19 cells/100 cells in Blood
24
99
2.43
3.96
1.5
2.1
%
11.0
7.1
0.57
24
94
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
70
424
1.66
3.95
1.3
1.5
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
12
33
3.64
3.92
1.4
1.2
%
23.3
24.9
—
7
21
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
35
171
2.05
3.89
2.6
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
35
171
2.05
3.89
2.6
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
35
171
2.05
3.89
2.6
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
35
171
2.05
3.89
2.5
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
57
328
1.75
3.88
2.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
57
328
1.75
3.88
2.1
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
57
328
1.75
3.88
2.1
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
142
1011
1.41
3.82
3.9
4.2
mmol/l
2.6
2.5
0.11
94
685
(3011985) Renin [Units/volume] in Plasma
94
618
1.53
3.79
1.5
1.4
mu/l
33.1
62.2
2.19
85
549
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
13
39
3.34
3.75
1.8
1.4
ng/l
74.2
84.4
—
6
14
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
63
377
1.68
3.74
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
119
828
1.45
3.65
4.5
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
542
4614
1.19
3.62
4.2
3.6
mmol/l
1.8
1.9
0.31
449
3763
(3019150) Specific gravity of Urine by Refractometry
946
10596
0.87
3.62
4.1
4.2
kg/l
1.0
1.0
0.40
129
1582
(3010421) pH of Blood
162
1194
1.37
3.58
4.2
4.0
ph
7.4
7.4
0.80
140
988
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
126
895
1.42
3.47
1.5
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
94
631
1.50
3.47
2.1
2.2
mg/l
23.2
24.4
0.08
26
162
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
14
47
2.98
3.41
5.4
5.2
ug/min
63.6
40.0
0.46
14
35
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
19
76
2.50
3.37
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
140
1020
1.38
3.35
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
366
3026
1.22
3.34
2.4
2.4
au/ml
30.5
25.0
0.30
15
130
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
178
1347
1.33
3.34
1.4
1.5
g/l
1.2
1.2
0.22
169
1268
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
182
1.93
3.32
1.1
1.1
ug/l
2.7
2.6
0.04
26
151
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
47
269
1.75
3.31
1.1
1.1
mg/l
508.8
270.1
0.71
37
237
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
49
284
1.73
3.31
1.1
1.2
mg/l
90.3
37.6
0.63
40
237
(3004716) Salmonella sp identified in Stool by Organism specific culture
242
1913
1.28
3.29
1.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
176
1.94
3.27
2.5
2.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
540
4640
1.18
3.26
4.2
3.6
kpa
5.9
5.8
0.57
526
4499
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
32
163
1.97
3.23
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
39
213
1.84
3.21
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
70
450
1.56
3.18
1.8
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
68
435
1.57
3.16
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
68
435
1.57
3.16
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
143
1058
1.36
3.13
1.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
70
452
1.56
3.12
1.3
1.4
mosm/kgh2o
282.9
277.8
1.38
57
341
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
132
965
1.38
3.12
1.3
1.3
e6/l
7.9
24.7
1.51
97
754
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
334
2758
1.22
3.11
1.3
1.3
au/ml
50.5
49.6
0.02
15
113
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
132
966
1.37
3.10
1.3
1.4
e6/l
477.6
1199.4
1.13
102
797
(3004588) Protein electrophoresis panel - Serum or Plasma
408
3437
1.20
3.10
2.5
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
731
6459
1.15
3.08
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
105
741
1.42
3.05
1.3
1.4
—
—
—
0
0
(4027681)
38
210
1.81
3.03
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3984
38604
1.10
2.90
24.4
17.7
g/l
331.7
332.2
3.25
3963
38275
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
273
1.69
2.89
1.6
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
141
1056
1.34
2.88
1.3
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
45
266
1.70
2.87
1.8
1.5
u/l
10.1
6.6
0.26
27
111
(3023419) Bacteria identified in Sputum by Culture
36
625
0.57
2.87
2.6
2.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
82
560
1.47
2.85
1.3
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
51
313
1.63
2.84
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
118
862
1.38
2.83
1.3
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
83
2.29
2.83
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
62
400
1.56
2.81
2.1
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
18
4.45
2.79
1.0
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
168
1298
1.30
2.78
1.4
1.4
ug/g
287.4
286.1
0.03
113
776
(3012565) Volume of 24 hour Urine
37
209
1.78
2.77
2.5
2.1
ml
1846.8
1949.4
0.26
31
178
(3028026) IgM [Mass/volume] in Serum or Plasma
283
2328
1.23
2.77
1.9
1.4
g/l
1.4
1.2
0.65
250
2113
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
78
2.31
2.74
1.6
2.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
22
104
2.12
2.74
1.6
2.5
e6/l
36894.3
33850.4
0.03
11
54
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
79
542
1.46
2.70
1.2
1.3
nmol/l
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
28
147
1.91
2.64
31.0
33.0
ug/l
6.8
7.5
1.17
23
136
(3037692) Legionella sp identified in Specimen by Organism specific culture
27
140
1.93
2.64
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
43
258
1.67
2.63
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2420
23002
1.09
2.62
4.8
5.0
estimate
0.0
0.0
0.80
483
3957
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
83
579
1.44
2.62
1.3
1.3
pmol/l
315.1
275.8
0.45
64
436
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
14
55
2.55
2.61
1.6
1.5
%
16.7
7.6
—
6
25
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
229
1858
1.24
2.57
1.9
1.8
u/l
41.0
38.4
1.05
203
1584
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
25
3.60
2.57
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2444
23266
1.09
2.52
3.7
3.7
estimate
0.0
0.0
1.60
466
3821
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
144
1109
1.31
2.48
1.3
1.2
mg/l
538.7
524.1
0.15
134
1038
(3020891) Body temperature
249
2048
1.23
2.47
4.8
4.8
—
—
—
0
0
(44806118)
67
454
1.48
2.47
1.4
1.4
—
—
—
0
0
(44790048)
67
454
1.48
2.47
1.4
1.4
—
—
—
0
0
(44790049)
67
454
1.48
2.47
1.4
1.4
—
—
—
0
0
(44790047)
67
454
1.48
2.47
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
83
590
1.41
2.39
1.3
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
17
4.12
2.36
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
83
594
1.40
2.31
2.2
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
47
301
1.57
2.26
2.8
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
61
414
1.48
2.26
3.6
2.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
35
208
1.69
2.26
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1040
11272
0.91
2.22
1.7
1.7
pmol/l
31415310.2
33091216.2
0.03
834
9208
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
9
5.56
2.21
1.2
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
146
1147
1.28
2.20
1.9
1.9
mg/l
11.4
11.4
0.04
138
1050
(3011397) Hemoglobin [Presence] in Urine by Test strip
1216
11289
1.10
2.19
3.4
3.7
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
24
3.34
2.18
2.1
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
19
94
2.02
2.15
2.1
2.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
52
347
1.50
2.11
1.3
1.3
mmol/l
11.4
12.0
0.20
20
98
(3024928) Oxygen saturation in Venous blood
131
1022
1.29
2.10
2.9
3.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
22
116
1.90
2.10
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
84
614
1.37
2.10
1.2
1.3
nmol/l
0.6
2.3
0.50
77
589
(3048879) Bone marrow aspiration report
21
109
1.93
2.10
2.2
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
15
4.00
2.04
1.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
84
618
1.36
2.03
1.2
1.3
nmol/l
0.2
0.4
0.74
11
42
(3025941) Bacteria identified in Stool by Culture
282
2400
1.18
2.01
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
129
1011
1.28
2.01
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
129
1011
1.28
2.01
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
44
2.50
2.01
1.3
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
63
2.23
2.00
2.6
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
124
969
1.29
1.98
1.2
1.2
mmol/l
3.7
3.9
1.25
115
901
(3035350) Ketones [Presence] in Urine by Test strip
2400
22991
1.07
1.97
3.6
3.7
estimate
0.0
0.0
0.80
471
3894
(3003740) Influenza virus B Ag [Presence] in Specimen
67
477
1.41
1.97
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
57
2.28
1.97
5.2
4.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
21
112
1.88
1.95
1.5
1.5
%
4.9
2.2
0.51
15
95
(3033799) Differential panel - Peritoneal fluid
20
105
1.91
1.95
2.0
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
73
529
1.38
1.94
1.7
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
85
1131
0.75
1.93
1.1
1.1
u/ml
4.0
6.7
—
10
103
(3002523) Influenza virus A Ag [Presence] in Specimen
67
479
1.40
1.93
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
694
6312
1.11
1.89
4.9
4.9
%
33.0
32.9
0.06
449
4225
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
18
92
1.96
1.89
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
46
307
1.50
1.89
2.5
2.1
min
493.1
496.5
0.08
33
232
(3005988) Vibrio sp identified in Specimen by Organism specific culture
73
532
1.38
1.89
1.7
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
162
1316
1.24
1.89
1.5
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
863
7941
1.10
1.88
1.6
1.3
g/l
2.3
2.6
3.52
492
4555
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
24
136
1.77
1.86
1.5
1.4
%
56.5
63.9
0.46
18
111
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
205
1.61
1.85
1.1
1.1
u/l
1.0
1.1
0.13
19
92
(3023487) Leukocytes [#/volume] in Peritoneal fluid
22
122
1.81
1.83
1.8
2.8
e6/l
24018.3
667.7
0.46
12
91
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
95
726
1.31
1.82
1.2
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
66
2.12
1.81
11.4
12.4
mmol/l
4.1
5.4
2.57
14
66
(4010399)
314
3609
0.86
1.80
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
21
116
1.81
1.78
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
72
530
1.36
1.77
1.7
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
62
446
1.39
1.75
1.1
1.1
—
43.3
—
0
10
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
182
1510
1.21
1.75
3.5
1.5
ratio
1.3
2.3
—
10
133
(3033705) Calcium.ionized [Moles/volume] in Venous blood
46
664
0.69
1.75
2.7
2.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
88
1.93
1.74
3.6
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
47
675
0.69
1.74
2.6
2.1
mmol/l
4.1
4.1
0.12
47
669
(3035285) Chloride [Moles/volume] in Venous blood
47
675
0.69
1.74
2.6
2.1
mmol/l
105.7
106.0
0.26
47
669
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
64
464
1.38
1.73
1.1
1.1
—
2.3
—
0
7
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
75
558
1.35
1.73
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
721
6608
1.10
1.71
8.3
7.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
141
1143
1.24
1.70
3.5
3.2
nmol/l
0.8
0.8
0.34
109
898
(40767503) Oxygen content in Capillary blood by calculation
123
984
1.26
1.68
2.4
2.5
%
15.8
16.4
0.68
70
525
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
12
55
2.18
1.67
1.3
1.2
ug/l
72.3
127.7
—
6
31
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
41
276
1.49
1.65
1.5
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
42
285
1.48
1.63
1.2
1.0
nmol/l
3.2
8.6
—
10
63
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
75
565
1.33
1.62
5.1
6.3
mg/l
12.2
12.0
0.11
69
506
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
352
3108
1.14
1.61
1.8
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
72
540
1.34
1.60
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
29
182
1.60
1.59
1.1
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
433
3877
1.13
1.59
3.2
3.0
kpa
4.6
4.5
0.41
417
3745
(3048689) Calprotectin [Mass/mass] in Stool
551
5002
1.11
1.59
2.1
2.2
ug/g
131.3
147.5
0.37
435
3913
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
40
271
1.48
1.58
1.5
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
(4034850)
143
1734
0.82
1.57
10.6
9.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
249
1.49
1.52
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
27
2.59
1.51
1.1
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
35
233
1.51
1.51
1.2
1.1
u/l
23.0
24.6
0.08
29
169
(3007566) Smooth muscle Ab [Titer] in Serum
139
1143
1.22
1.51
1.3
1.2
titre
566.0
158.8
—
10
98
(3017569) Oxygen content in Arterial blood
15
270
0.55
1.50
1.5
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
35
234
1.50
1.48
1.2
1.1
u/l
80.0
84.7
0.20
30
176
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
226
1.51
1.48
1.2
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
184
1557
1.19
1.48
3.5
1.6
mg/l
58.4
38.8
0.42
156
1256
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
71
539
1.32
1.48
1.7
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
313
2762
1.14
1.47
2.5
2.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
35
235
1.49
1.46
1.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
184
1561
1.18
1.45
3.5
1.6
mg/l
51.4
47.7
0.25
154
1266
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
27
414
0.65
1.44
1.0
1.0
ng/l
257.8
332.5
0.70
18
269
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
35
236
1.49
1.43
1.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
22
2.73
1.43
2.8
3.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
136
1126
1.21
1.40
2.0
2.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
55
406
1.36
1.39
1.7
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
11
212
0.52
1.39
19.3
17.2
nmol/l
1694.5
1394.7
0.72
11
204
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
53
2.08
1.38
2.4
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
114
929
1.23
1.37
2.5
2.5
umol/l
32.4
34.5
0.41
91
789
(3019832) Treponema pallidum Ab [Presence] in Serum
243
2119
1.15
1.37
1.5
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
72
555
1.30
1.37
1.0
1.1
g/l
1.4
1.5
2.60
67
487
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
23
2.61
1.36
7.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
698
7526
0.92
1.36
1.3
1.3
u/ml
13.6
14.4
0.09
260
2840
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
28
420
0.67
1.36
1.0
1.0
ng/l
30.9
45.3
1.50
19
268
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
156
1314
1.19
1.35
1.4
1.6
g/l
0.2
0.2
0.42
146
1242
(4268621)
54
400
1.35
1.35
2.5
2.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
50
674
0.74
1.33
3.8
4.6
umol/l
339.0
357.3
0.37
40
571
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
28
417
0.67
1.32
1.0
1.0
ng/l
537.4
717.4
1.41
16
264
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
51
376
1.36
1.31
1.3
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
45
325
1.39
1.31
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
176
1503
1.18
1.31
2.9
2.5
g/l
0.3
0.3
1.16
92
515
(1761482) Bacteria [#/volume] in Urine by Culture
113
1372
0.82
1.30
3.9
4.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
98
1.74
1.30
1.2
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
20
121
1.66
1.30
5.5
5.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
51
377
1.36
1.30
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
51
377
1.36
1.30
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
137
1146
1.20
1.29
1.3
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
349
3131
1.12
1.29
3.0
2.9
e9/l
4.1
4.1
0.00
257
2265
(3007930) Methemoglobin/Hemoglobin.total in Blood
179
2082
0.86
1.28
3.5
4.8
%
0.9
0.9
0.39
166
1954
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
51
378
1.35
1.28
1.3
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
342
0.64
1.28
7.9
2.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
62
1.94
1.27
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
70
544
1.29
1.27
1.7
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
35
2.29
1.26
1.8
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
43
311
1.39
1.25
1.3
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
18
107
1.68
1.25
1.6
1.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
16
92
1.74
1.24
2.6
1.8
%
12.3
8.5
0.40
16
85
(3036525) Urea [Moles/time] in 24 hour Urine
6
25
2.40
1.24
4.5
2.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
118
0.42
1.24
1.4
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
203
0.54
1.24
12.9
12.3
nmol/l
1072.1
800.5
0.71
11
191
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
54
407
1.33
1.23
1.4
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
282
2507
1.13
1.22
2.6
2.6
e6/l
0.2
0.3
0.68
276
2445
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
313
1.38
1.22
1.3
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
71
557
1.28
1.21
1.7
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
37
2.16
1.21
2.0
2.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
37
2.16
1.21
1.8
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
44
322
1.37
1.21
1.3
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
183
2107
0.86
1.17
3.4
4.7
%
1.5
1.6
1.46
169
1976
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
57
1.93
1.17
1.1
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
561
1.27
1.16
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
182
1.49
1.15
1.1
1.1
ng/l
70.1
548.3
—
7
45
(4212803)
8
39
2.05
1.15
1.3
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
74
589
1.26
1.14
1.3
1.2
u/ml
5.1
4.8
0.05
35
252
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
29
199
1.46
1.14
1.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
29
199
1.46
1.14
1.5
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
65
1.85
1.13
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
586
0.75
1.12
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
748
7974
0.93
1.12
1.3
1.3
iu/ml
31.4
36.7
0.57
220
2452
(3025315) Body weight
8
40
2.00
1.12
6.0
5.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
81
656
1.24
1.09
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
131
1113
1.18
1.08
1.9
2.2
g/l
126.9
130.4
0.86
101
823
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
33
235
1.41
1.08
1.0
1.1
iu/ml
7.7
11.6
—
7
61
(3045414) Leukocytes [Presence] in Urine
243
2161
1.13
1.08
1.8
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
17
267
0.64
1.07
1.2
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
43
321
1.34
1.07
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
54
693
0.78
1.07
1.6
1.5
%
56.0
61.2
0.42
34
447
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
56
435
1.29
1.06
1.5
1.7
u/ml
33.4
24.4
0.44
11
103
(3028271) Lactate [Moles/volume] in Capillary blood
89
731
1.22
1.06
1.8
1.9
mmol/l
1.6
1.7
0.36
84
714
(3004616) Nuclear Ab [Presence] in Serum
46
602
0.76
1.05
1.5
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
43
322
1.34
1.05
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
43
322
1.34
1.05
1.1
1.1
—
—
—
0
0
(44806420)
10
179
0.56
1.04
2.0
2.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
67
1.79
1.04
1.3
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
67
1.79
1.04
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
283
3139
0.90
1.04
1.2
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
348
0.69
1.04
1.5
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
537
4987
1.08
1.03
2.3
2.4
ug/l
7.5
7.5
0.01
460
4316
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
31
221
1.40
1.02
1.2
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
31
221
1.40
1.02
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
107
1267
0.84
1.01
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
43
325
1.33
1.00
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
43
325
1.33
1.00
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
135
1160
1.17
0.99
1.3
1.2
titre
448.3
1152.8
—
6
32
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
43
326
1.32
0.98
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
293
2652
1.11
0.98
1.2
1.3
u/ml
124.0
223.1
4.64
273
2448
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
23
2.17
0.98
2.8
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
23
2.17
0.98
5.6
6.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
451
4871
0.92
0.97
1.7
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
43
327
1.32
0.97
1.2
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
27
191
1.42
0.94
1.2
1.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
15
93
1.61
0.93
2.6
1.8
%
30.7
27.1
0.34
15
87
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
27
2.22
0.93
10.5
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
69
562
1.23
0.92
1.2
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
35
261
1.34
0.91
1.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
144
1255
1.15
0.90
2.4
3.1
mmol/l
24.3
24.8
0.68
125
1102
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
360
0.72
0.90
1.0
1.4
promille
2.1
1.3
1.37
15
277
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
141
1228
1.15
0.90
1.7
1.8
—
—
—
0
0
(3019977) pH of Arterial blood
19
278
0.68
0.89
1.6
2.3
ph
7.4
7.4
—
7
104
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
473
0.76
0.88
1.0
1.1
u/ml
0.5
0.7
0.32
13
185
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
242
0.66
0.88
1.3
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
333
3056
1.10
0.87
3.4
3.5
ph
7.4
7.4
0.02
49
368
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
8
43
1.86
0.87
1.0
1.2
u/ml
0.0
0.5
—
8
23
(40768446) Kidney Pathology biopsy report
23
161
1.43
0.86
2.1
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
221
1.36
0.85
1.1
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
337
3101
1.09
0.84
3.4
3.5
kpa
5.0
5.2
3.64
311
2836
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
261
2373
1.10
0.84
2.8
2.6
%
0.7
0.7
0.40
254
2264
(3019309) Folate [Moles/volume] in Red Blood Cells
1086
10407
1.05
0.84
1.8
1.8
nmol/l
1138.3
1154.0
0.21
804
7807
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
76
633
1.20
0.83
1.6
1.8
u/l
902.5
3701.7
1.82
20
261
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
141
0.57
0.82
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
141
0.57
0.82
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
141
0.57
0.82
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
141
0.57
0.82
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
32
1.88
0.81
1.3
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
20
138
1.45
0.81
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
177
0.62
0.81
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
56
454
1.24
0.80
1.4
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
45
565
0.79
0.80
1.0
1.1
u/ml
1.2
1.4
0.12
18
218
(3020393) Adenovirus Ag [Presence] in Stool
6
33
1.82
0.79
1.2
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
38
486
0.78
0.79
1.1
1.1
u/ml
3.0
3.0
0.02
18
224
(1002224) Polysomnography panel
178
1592
1.12
0.78
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
320
2950
1.09
0.78
3.4
3.5
mmol/l
1.4
1.8
1.35
236
2143
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
50
402
1.25
0.78
1.3
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
13
82
1.59
0.78
1.3
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
123
1.46
0.77
2.3
2.0
ug/l
1.0
1.0
0.00
18
113
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
36
278
1.30
0.77
2.3
2.2
ug/min
9.7
188.4
—
7
75
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
54
1.67
0.74
2.0
2.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
55
1.64
0.73
2.0
2.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
172
1544
1.12
0.73
4.5
4.5
mmol/l
3.9
3.9
0.39
164
1449
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
26
193
1.35
0.73
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
45
361
1.25
0.72
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
14
92
1.52
0.72
1.1
1.1
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
5
26
1.92
0.70
1.2
1.2
—
1.1
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
46
372
1.24
0.70
1.8
2.2
%
10.4
11.1
0.43
46
372
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
111
973
1.14
0.69
1.5
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
308
0.75
0.69
1.2
1.3
pmol/l
92.6
168.9
—
5
89
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
34
266
1.28
0.68
2.1
1.5
u/l
7.1
6.5
0.12
24
227
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
114
1292
0.88
0.67
1.6
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
32
249
1.29
0.67
2.5
2.4
—
—
—
0
0
(44813793)
20
272
0.73
0.66
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
262
2418
1.09
0.66
2.8
2.6
%
1.2
1.2
0.01
262
2403
(3028300) Cannabinoids [Presence] in Urine
64
755
0.85
0.65
3.6
1.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
62
1.61
0.65
1.9
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
260
1.27
0.63
1.2
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
16
112
1.43
0.63
1.1
1.1
%
88.0
89.4
—
7
54
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
112
1.43
0.63
1.1
1.1
%
82.1
87.7
—
7
52
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
28
216
1.30
0.63
1.1
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
44
535
0.82
0.62
1.3
1.3
mmol/l
7.2
7.6
0.52
34
383
(1001926) Buprenorphine [Presence] in Urine by Screen method
49
589
0.83
0.62
4.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
64
751
0.85
0.62
3.6
1.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
103
0.58
0.62
1.0
1.2
umol/l
15.7
16.2
—
6
96
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
302
0.76
0.62
1.6
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
208
1.30
0.61
1.2
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
13
187
0.69
0.60
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
64
748
0.85
0.60
3.6
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
32
400
0.80
0.59
1.3
1.2
—
44.6
—
0
29
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
499
4737
1.06
0.59
2.4
3.0
ng/l
233.3
223.3
0.18
448
4343
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
14
97
1.44
0.59
2.0
2.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
97
1.44
0.59
1.3
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
44
363
1.21
0.58
1.2
1.4
titre
20.0
80.0
—
5
33
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
35
1.71
0.57
1.5
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
54
1.48
0.57
1.4
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
100
886
1.13
0.57
2.2
2.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
70
605
1.16
0.56
1.3
1.2
u/ml
2.9
4.1
0.29
18
190
(3000034) Microalbumin [Mass/volume] in Urine
43
517
0.83
0.56
3.0
3.1
mg/l
19.0
35.5
1.34
31
380
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
23
176
1.31
0.56
3.0
2.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
59
689
0.85
0.56
3.8
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
55
1.46
0.56
1.4
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
15
107
1.40
0.55
1.7
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
33
266
1.24
0.55
1.4
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
339
0.80
0.53
1.0
1.1
u/ml
0.9
2.8
—
10
130
(3006462) Nitrate [Presence] in Urine
28
222
1.26
0.53
3.9
3.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
258
1.24
0.53
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
96
853
1.13
0.53
1.3
1.3
mmol/l
61.9
63.5
0.15
78
683
(3019174) dRVVT (LA screen)
6
39
1.54
0.53
1.2
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
62
1.45
0.53
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
117
1053
1.11
0.53
1.4
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
165
1797
0.92
0.52
1.2
1.2
u/ml
0.3
0.8
2.29
13
176
(3027944) Amphetamines [Presence] in Urine
64
736
0.87
0.51
3.0
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
22
170
1.30
0.51
6.3
1.6
%
144.2
151.9
0.19
22
159
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
50
425
1.18
0.51
1.9
1.8
titre
13168.0
1740.0
—
5
16
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
109
1.38
0.50
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
168
0.71
0.50
1.2
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
41
1.46
0.50
1.2
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
98
1092
0.90
0.49
3.0
3.7
mg/l
26.9
27.6
0.07
60
718
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
45
1.56
0.48
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
30
367
0.82
0.48
1.0
1.1
u/ml
0.5
2.4
—
9
140
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
178
0.73
0.48
1.0
1.1
miu/ml
1766.8
1636.5
0.16
13
178
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
18
234
0.77
0.48
1.3
1.3
mmol/l
5.9
6.1
0.36
18
222
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
61
698
0.87
0.47
1.0
1.1
iu/ml
32.7
1405.3
0.90
12
149
(3000492) Spirometry study
430
4099
1.05
0.47
1.5
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
79
701
1.13
0.47
1.7
1.6
g/l
0.6
0.8
2.49
64
532
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
29
236
1.23
0.46
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
24
299
0.80
0.46
1.0
1.1
u/ml
0.0
0.3
—
6
77
(3001019) Free T4 and TSH panel - Serum or Plasma
182
1688
1.08
0.46
1.5
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
114
1035
1.10
0.46
2.3
2.8
kpa
7.9
7.9
0.02
102
954
(1761868) Lipid panel - Serum or Plasma
1538
15046
1.03
0.46
3.0
3.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
5
81
0.62
0.45
1.0
1.7
—
88.3
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
66
749
0.88
0.45
1.4
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
119
0.67
0.45
6.8
6.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
11
77
1.43
0.45
1.1
1.2
mmol/l
1.1
1.4
—
5
40
(3000285) Sodium [Moles/volume] in Blood
5
84
0.59
0.45
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
50
1.40
0.45
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
192
2061
0.93
0.45
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
277
2936
0.94
0.45
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
220
2060
1.07
0.44
1.5
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
52
452
1.15
0.42
2.6
2.3
ml
670.3
620.9
0.40
35
307
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
45
387
1.16
0.42
1.7
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
32
1.56
0.42
2.2
1.8
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.6
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.6
umol/l
0.6
0.7
—
5
22
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
12.4
—
0
15
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
4.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
351
1.17
0.41
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
14
105
1.33
0.41
1.8
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
59
1.36
0.41
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
80
719
1.11
0.40
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
30
358
0.84
0.40
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
141
1.28
0.40
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
144
1335
1.08
0.39
1.6
1.5
e6/l
10019.9
13440.5
0.89
98
971
(3024891) Influenza virus A+B Ag [Presence] in Specimen
116
1066
1.09
0.39
1.1
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
138
1488
0.93
0.38
3.9
5.9
mmol/l
1.3
1.3
0.20
121
1310
(3041096) Erythrocytes [Presence] in Urine by Automated
1213
11863
1.03
0.38
3.5
3.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
63
705
0.89
0.37
1.4
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1323
12959
1.03
0.37
1.6
1.6
mmol/l
1.3
1.3
0.90
1087
10748
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
113
0.71
0.37
1.1
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.1
u/ml
0.0
3.0
—
5
23
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
107
1.31
0.37
1.6
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1666
16953
0.98
0.37
4.2
4.0
mg/mmol
6.7
8.8
1.47
1028
10752
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
88
801
1.10
0.36
1.2
1.2
u/l
98.9
27.6
1.19
78
686
(3019060) Gas panel - Arterial blood
346
3310
1.05
0.36
3.9
4.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
227
2150
1.06
0.35
1.6
1.5
u/ml
11.6
17.6
—
9
49
(3028717) Thiamine [Mass/volume] in Blood
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1750
17782
0.98
0.34
3.9
4.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
82
1.34
0.34
1.3
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
45
1.33
0.33
1.0
1.2
umol/24h
2.1
1.8
—
6
45
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
42
476
0.88
0.32
1.2
1.1
—
1.7
—
0
15
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
203
1924
1.06
0.32
4.0
3.8
mmol/l
24.6
24.9
0.74
182
1748
(3018572) Chloride [Moles/volume] in Blood
96
1039
0.92
0.31
4.5
6.7
mmol/l
105.5
104.9
0.79
84
930
(3039000) Anion gap in Blood
96
1038
0.92
0.31
4.5
6.7
mmol/l
11.1
11.4
0.34
84
929
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
400
0.87
0.30
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
100
0.70
0.30
1.9
1.5
ng/l
132.9
118.1
—
7
100
(3027923) C peptide [Moles/volume] in Serum or Plasma
23
272
0.84
0.30
1.4
1.4
nmol/l
1.2
1.3
0.17
13
209
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
54
1.30
0.30
2.4
2.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
25
212
1.18
0.30
1.1
1.2
%
73.0
48.2
—
5
22
(3005011) Chlamydia sp Ab [Titer] in Serum
7
55
1.27
0.30
1.4
1.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
13
163
0.80
0.29
1.0
1.1
%
101.2
93.5
0.49
13
126
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
31
356
0.87
0.29
1.4
1.2
titre
104.0
171.4
—
5
65
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
104
968
1.08
0.29
1.7
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
122
1143
1.07
0.28
3.9
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
91
843
1.08
0.28
1.3
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
270
0.85
0.28
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
103
1.26
0.28
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
128
1361
0.94
0.27
1.5
1.6
iu/ml
0.1
2.5
0.64
24
299
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
51
460
1.11
0.27
3.7
3.8
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
30
261
1.15
0.27
1.3
1.4
—
1.5
—
0
25
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
269
0.85
0.27
1.1
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
118
0.76
0.27
4.3
7.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
150
0.80
0.27
1.3
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
150
0.80
0.27
1.3
2.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
113
1.24
0.26
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
416
0.89
0.26
1.0
1.1
u/ml
0.0
1.7
—
7
93
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
268
0.86
0.26
1.1
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
104
1.25
0.26
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
86
1.28
0.26
1.4
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
124
1.21
0.24
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
13
106
1.23
0.23
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
39
1.28
0.23
1.0
2.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
42
463
0.91
0.22
1.4
1.4
g/l
7.3
6.7
0.24
31
327
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
232
0.86
0.22
1.1
1.1
—
—
—
0
0
(4211845)
28
247
1.13
0.22
3.9
2.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
42
462
0.91
0.22
1.4
1.4
g/l
2.3
2.9
1.80
31
326
(3024139) IgG subclass 3 [Mass/volume] in Serum
42
462
0.91
0.22
1.4
1.4
g/l
0.7
0.4
0.40
30
328
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.1
u/l
14.6
16.3
—
5
41
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
38
343
1.11
0.22
1.4
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
231
0.87
0.21
1.3
1.1
ratio
1.1
1.1
—
6
73
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
51
468
1.09
0.21
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
30
267
1.12
0.21
1.4
1.4
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
154
1.17
0.21
1.1
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(4306422)
63
585
1.08
0.21
1.3
1.2
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
6
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
62
576
1.08
0.20
2.8
19.9
mmol/l
6.6
7.4
1.55
47
472
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.4
—
2.3
—
0
14
(3029937) Albumin [Presence] in Urine by Test strip
1278
12616
1.02
0.20
4.2
4.1
estimate
0.0
0.0
1.74
452
3846
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
95
1005
0.94
0.20
1.2
1.2
—
16.9
—
0
14
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
49
1.22
0.20
1.3
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
111
0.81
0.20
1.1
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
110
1158
0.95
0.20
1.4
1.8
nmol/l
44.9
43.9
0.19
110
1104
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
47
510
0.92
0.19
1.1
1.1
u/ml
1.5
3.2
1.53
17
208
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
111
1167
0.95
0.19
1.2
1.2
u/ml
2.0
8.1
—
7
124
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
154
0.84
0.19
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
140
1462
0.96
0.19
1.9
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
53
1.13
0.18
1.5
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
164
0.85
0.18
2.6
1.9
ug/l
46.8
51.9
0.21
14
159
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
25
223
1.12
0.18
1.7
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
185
1.14
0.18
1.4
2.3
umol/l
107.2
146.3
0.53
13
102
(3000330) Specific gravity of Urine by Test strip
256
2637
0.97
0.18
3.1
3.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
216
0.88
0.17
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
36
329
1.09
0.17
1.2
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
12
142
0.84
0.17
1.2
1.3
%
43.4
35.1
—
7
89
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
62
1.13
0.17
1.3
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
13
110
1.18
0.17
1.2
1.4
—
—
—
0
0
(4133840)
13
110
1.18
0.17
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
50
465
1.08
0.17
1.1
1.3
nmol/l
1.4
1.4
0.05
43
416
(3020491) Glucose [Moles/volume] in Blood
39
359
1.09
0.16
2.2
2.2
mmol/l
7.6
6.7
0.73
28
238
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
282
1.10
0.16
1.4
1.7
umol/l
8.4
6.6
0.29
23
194
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
139
1.15
0.16
1.4
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
930
9419
0.98
0.15
1.3
1.2
u/ml
1.7
1.9
0.30
213
2482
(3022313) Gas panel - Capillary blood
229
2228
1.03
0.15
3.8
3.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
274
2673
1.03
0.15
1.3
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
7
86
0.81
0.14
1.0
1.1
—
3.3
—
0
10
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
275
1.09
0.14
1.1
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
131
1.15
0.14
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
122
1.15
0.13
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
143
1385
1.03
0.13
2.5
2.3
ug/min
69.2
120.5
1.56
90
810
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
114
1181
0.96
0.12
1.2
1.2
u/ml
2.9
5.0
—
10
196
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
148
0.88
0.12
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
54
570
0.95
0.12
1.2
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
104
1.15
0.12
1.2
1.1
—
—
—
0
0
(4094501)
144
1397
1.03
0.12
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
603
6110
0.99
0.12
1.3
1.3
titre
509.3
525.5
0.08
116
1344
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
79
824
0.96
0.12
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
29
313
0.93
0.12
1.4
1.2
u/ml
0.1
1.1
1.52
16
151
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
81
844
0.96
0.12
1.6
1.9
pmol/l
198.2
198.8
0.02
76
790
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
137
0.88
0.12
4.2
7.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
230
2249
1.02
0.11
1.6
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
146
1502
0.97
0.11
1.3
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
172
1676
1.03
0.11
1.5
1.6
titre
116.7
318.6
—
6
83
(3045424) Erythrocytes [Presence] in Urine
76
792
0.96
0.11
1.5
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
47
446
1.05
0.10
1.3
1.4
—
24.5
—
0
21
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
146
0.89
0.10
1.9
1.5
ug/l
7.3
9.1
1.85
13
146
(3009508) Creatinine [Moles/volume] in Urine
1637
16470
0.99
0.10
3.4
3.2
mmol/l
7.3
7.4
0.98
1373
13734
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
92
889
1.04
0.10
1.2
1.2
u/ml
58.7
41.1
—
7
102
(36660697) Celiac disease serology panel - Serum
348
3426
1.02
0.10
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
101
979
1.03
0.09
1.5
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
412
0.95
0.09
1.7
2.2
u/field
2.3
1.8
0.19
20
157
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
62
645
0.96
0.09
1.3
1.3
—
—
—
0
0
(4062490)
44
462
0.95
0.09
1.4
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.2
1.5
umol/l
43.8
43.3
—
6
54
(3018133) Calcium [Moles/volume] in Urine
6
57
1.05
0.08
2.0
1.7
mmol/l
2.5
2.8
—
6
49
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
19
175
1.09
0.08
1.3
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
491
0.96
0.08
6.6
2.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
1.1
1.9
umol/l
13.7
18.1
—
7
66
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
7
68
1.03
0.07
1.3
1.3
nmol/l
7.4
458629.0
—
7
58
(3008152) Bicarbonate [Moles/volume] in Arterial blood
314
3181
0.99
0.07
6.4
6.9
mmol/l
24.7
24.6
0.23
292
2940
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
146
1431
1.02
0.07
1.8
1.7
mg/l
2.6
3.7
1.15
109
1012
(3022621) pH of Urine by Test strip
320
3240
0.99
0.07
2.8
3.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
84
0.83
0.07
1.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
84
1.07
0.07
1.4
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
118
1.10
0.07
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1600
16069
0.99
0.07
3.5
3.2
mg/l
564.6
307.2
1.08
1004
10238
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
105
0.86
0.06
1.1
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
325
1.05
0.06
1.3
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
111
0.90
0.06
1.5
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
43
446
0.96
0.06
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
25
237
1.06
0.05
1.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
320
3170
1.01
0.05
3.0
3.2
g/l
126.8
130.2
1.75
311
3081
(3039443) Prostate specific Ag panel - Serum or Plasma
88
862
1.02
0.05
1.8
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
16
171
0.94
0.05
1.3
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
120
1.08
0.04
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
58
594
0.98
0.04
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
98
964
1.02
0.04
1.8
1.6
nmol/l
0.9
0.8
0.21
84
794
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
72
734
0.98
0.03
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
196
1941
1.01
0.03
1.1
1.1
titre
35.0
194.0
—
6
52
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
131
1.07
0.03
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
34
329
1.03
0.03
1.5
1.4
g/l
1.0
0.9
0.33
34
329
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
462
4644
0.99
0.03
1.5
1.7
%
1.5
1.5
0.09
398
3995
(40761535) Cells panel - Urine sediment
433
4307
1.01
0.03
3.5
3.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
161
1.06
0.03
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
23
221
1.04
0.03
1.3
1.2
nmol/l
133.7
138.1
0.23
23
221
(4015189)
15
158
0.95
0.02
1.8
2.6
—
—
—
0
0
(4146454)
62
610
1.02
0.02
2.7
2.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
20
192
1.04
0.02
3.1
1.8
ug/l
16.7
197.8
0.68
20
181
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
163
1618
1.01
0.02
1.7
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
50
509
0.98
0.02
1.6
1.5
%
34.1
28.9
0.42
31
331
(3010144) Erythrocytes [#/volume] in Synovial fluid
54
531
1.02
0.02
1.3
1.3
e6/l
194654.4
191110.6
0.01
40
364
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
113
1.06
0.01
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
29
283
1.02
0.01
9.2
10.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
13
124
1.05
0.00
1.5
1.6
mmol/l
8.1
8.6
—
6
69
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
25
256
0.98
0.00
1.8
1.9
u/field
1.9
1.8
0.03
19
173
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
253
2524
1.00
0.00
1.7
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
98
1.02
0.00
2.0
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
132
0.98
0.00
1.2
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
22
222
0.99
0.00
1.0
1.1
—
3.8
—
0
14
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
115
1.04
0.00
1.0
1.1
—
—
—
0
0
(4024509)
49
488
1.00
0.00
1.3
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
29
285
1.02
0.00
2.2
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
31
305
1.02
0.00
2.6
2.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
10
96
1.04
0.00
1.2
1.2
umol/24h
0.9
0.7
—
5
45
(3009871) Measles virus Ab [Titer] in Serum
13
126
1.03
0.00
1.6
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
136
1.03
0.00
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
19
186
1.02
0.00
1.3
1.2
g/l
40.2
39.9
0.03
12
97
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
237
1.01
0.00
3.1
4.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
24
237
1.01
0.00
5.5
5.1
u/ml
788.0
53.6
—
5
46
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
58
584
0.99
0.00
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
101
0.99
0.00
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
592
5924
1.00
0.00
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
251
1.00
0.00
2.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
82
821
1.00
0.00
1.2
1.2
miu/ml
258.0
217.9
0.39
36
360
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
61
0.98
0.00
1.3
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
53
0.94
0.00
8.6
11.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
152.3
—
0
6
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
53
0.94
0.00
1.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
66
0.91
0.00
3.3
2.8
u/field
0.3
0.5
—
6
66
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
43.7
—
0
7
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
88
0.91
0.00
1.1
1.5
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.4
—
0
7
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
3.9
—
18.1
—
0
7
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
62
0.97
0.00
1.0
1.1
u/ml
85.0
59.7
—
6
62
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MELANOMA_SKIN_EXALLC – Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)
GWS hits: 25
This endpoint is excluded (different definition than used in FinnGen).